NDA Help Center

Collection - General Tab

Fields available for edit on the top portion of the page include:

  • Collection Title
  • Investigators
  • Collection Description
  • Collection Phase
  • Funding Source
  • Clinical Trials

Collection Status: The visibility status of an NDA Collection.  Collection Status can be Shared or Private.  Collections in Shared status are visible to all users and can be searched in the NDA Query Tool. Private Collections are not visible to NDA users.  The Status of an NDA Collection only affects the visibility of information about the Collection (metadata) and does not relate to the status of the record-level research data in the NDA Collection.

Collection Phase: The current status of a research project submitting data to an NDA Collection, based on the timing of the award and/or the data that have been submitted.
 

  • Pre-Enrollment: The default entry made when the NDA Collection is created.
     
  • Enrolling: Data have been submitted to the NDA Collection or the NDA Data Expected initial submission date has been reached for at least one data structure category in the NDA Collection.
     
  • Data Analysis: Subject level data collection for the research project is completed and has been submitted to the NDA Collection.  The NDA Collection owner or the NDA Help Desk may set this phase when they’ve confirmed data submission is complete and submitted subject counts match at least 90% of the target enrollment numbers in the NDA Data Expected. Data submission reminders will be turned off for the NDA Collection.
     
  • Funding Completed: The NIH grant award (or awards) associated with the NDA Collection has reached its end date. NDA Collections in Funding Completed phase are assigned a subphase to indicate the status of data submission.
     
    • The Data Expected Subphase indicates that NDA expects more data will be submitted
    • The Closeout Subphase indicates the data submission is complete.
    • The Sharing Not Met Subphase indicates that data submission was not completed as expected. 

Blinded Clinical Trial Status:

  • This status is set by a Collection Owner and indicates the research project is a double blinded clinical trial.  When selected, the public view of Data Expected will show the Data Expected items and the Submission Dates, but the targeted enrollment and subjects submitted counts will not be displayed.
     
  • Targeted enrollment and subjects submitted counts are visible only to NDA Administrators and to the NDA Collection or as the NDA Collection Owner.
     
  • When an NDA Collection that is flagged Blinded Clinical Trial reaches the maximum data sharing date for that Data Repository (see https://nda.nih.gov/about/sharing-regimen.html), the embargo on Data Expected information is released.
     

Funding Source

The organization(s) responsible for providing the funding is listed here. 

Supporting Documentation

Users with Submission privileges, as well as Collection Owners, Program  Officers, and those with Administrator privileges, may upload and attach supporting documentation. By default, supporting documentation is shared to the general public, however, the option is also available to limit this information to qualified researchers only. 

Grant Information 

Identifiable details are displayed about the Project of which the Collection was derived from. You may click in the Project Number to view a full report of the Project captured by the NIH. 

Clinical Trials

Any data that is collected to support or further the research of clinical studies will be available here. Collection Owners and those with Administrator privileges may add new clinical trials. 

Frequently Asked Questions

  • When a Collection is created by NDA staff and marked as Shared, an email notification will automatically be sent to the PI(s) of the grant(s) associated with the Collection to notify them.

  • During Collection creation, NDA staff determine the appropriate Permission Group based on the type of data to be submitted, the type of access that will be available to data access users, and the information provided by the Program Officer during grant award.

  • The NDA system does not allow for a single grant to be associated with more than one Collection; therefore, a single grant will not be listed in the Grant Information section of a Collection for more than one Collection.

  • In general, each Collection is associated with only one grant; however, multiple grants may be associated if the grant has multiple competing segments for the same grant number or if multiple different grants are all working on the same project and it makes sense to hold the data in one Collection (e.g., Cooperative Agreements).

Glossary

  • Number of human subjects enrolled in an NIH-funded clinical research study. The data is provided in annual progress reports.

  • A privilege provided to a user associated with an NDA Collection or NDA Study whereby that user can perform a full range of actions including providing privileges to other users. 

  • Generally, the Collection Owner is the contact PI listed on a grant. Only one NDA user is listed as the Collection owner. Most automated emails are primarily sent to the Collection Owner.

  • The Collection Phase provides information on data submission as opposed to grant/project completion so while the Collection phase and grant/project phase may be closely related they are often different.  Collection users with Administrative Privileges are encouraged to edit the Collection Phase.  The Program Officer as listed in eRA (for NIH funded grants) may also edit this field. Changes must be saved by clicking the Save button at the bottom of the page.  This field is sortable alphabetically in ascending or descending order. Collection Phase options include: 

    • Pre-Enrollment:  A grant/project has started, but has not yet enrolled subjects.
    • Enrolling:  A grant/project has begun enrolling subjects.  Data submission is likely ongoing at this point.
    • Data Analysis:  A grant/project has completed enrolling subjects and has completed all data submissions.
    • Funding Completed:  A grant/project has reached the project end date.
  • The Collection State indicates whether the Collection is viewable and searchable.  Collections can be either Private, Shared, or an Ongoing Study.  A Collection that is shared does not necessarily have shared data as the Collection State and state of data are independent of each other.  This field can be edited by Collection users with Administrative Privileges and the Program Officer as listed in eRA (for NIH funded grants). Changes must be saved by clicking the Save button at the bottom of the page.

  • An editable field with the title of the Collection, which is often the title of the grant associated with the Collection.

  • Data Use Limitations (DULs) describe the appropriate secondary use of a dataset and are based on the original informed consent of a research participant. NDA only accepts consent-based data use limitations defined by the NIH Office of Science Policy.

  • Provides the grant number(s) for the grant(s) associated with the Collection.  The field is a hyperlink so clicking on the Grant number will direct the user to the grant information in the NIH Research Portfolio Online Reporting Tools (RePORT) page.

  • A virtual container and organization structure for data and associated documentation from one grant or one large project/consortium. It contains tools for tracking data submission and allows investigators to define a wide array of other elements that provide context for the data, including all general information regarding the data and source project, experimental parameters used to collect any event-based data contained in the Collection, methods, and other supporting documentation. They also allow investigators to link underlying data to an NDA Study, defining populations and subpopulations specific to research aims. 

  • NDA Collections may be organized by scientific similarity into NIH Research Initiatives, to facilitate query tool user experience. NIH Research Initiatives map to one or multiple Funding Opportunity Announcements. 

  • Access to shared record-level data in NDA is provisioned at the level of a Permission Group. NDA Permission Groups consist of one or multiple NDA Collections that contain data with the same subject consents.

  • Number of human subject participants to be enrolled in an NIH-funded clinical research study. The data is provided in competing applications and annual progress reports.

  • Various documents and materials to enable efficient use of the data by investigators unfamiliar with the project and may include the research protocol, questionnaires, and study manuals.  

  • The total number of unique subjects for whom data have been shared and are available for users with permission to access data.

NDA Help Center

Collection - Shared Data Tab

This tab provides a quick overview of the Data Structure title, Data Type, and Number of Subjects that are currently Shared for the Collection. The information presented in this tab is automatically generated by NDA and cannot be edited. If no information is visible on this tab, this would indicate the Collection does not have shared data or the data is private.

The shared data is available to other researchers who have permission to access data in the Collection's designated Permission Group(s). Use the Download button to get all shared data from the Collection to the Filter Cart.

 

Frequently Asked Questions

  • To see what data your project have submitted are being used by a study, simply go the Associated Studies tab of your collection.  Alternatively, you may review an NDA Study Attribution Report available on the General tab.  

  • Often it becomes more difficult to organize and format data electronically after the project has been completed and the information needed to create a GUID may not be available; however, you may still contact a program staff member at the appropriate funding institution for more information.

  • Unlike completed projects where researchers may not have the information needed to create a GUID and/or where the effort needed to organize and format data becomes prohibitive, ongoing projects have more of an opportunity to overcome these challenges.  Please contact a program staff member at the appropriate funding institution for more information.

Glossary

  • A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure

  • A grouping of data by similar characteristics such as Clinical Assessments, Omics, or Neurosignal data.

  • The term 'Shared' generally means available to others; however, there are some slightly different meanings based on what is Shared.  A Shared NDA Collection or NDA Study is viewable and searchable publicly regardless of the user's role or whether the user has an NDA account.  A Shared Collection or NDA Study does not necessarily mean that data submitted to the Collection or used in the NDA Study have been shared as this is independently determined.  Data are shared according the schedule defined in a Collection's Data Expected Tab and/or in accordance with data sharing expectations in the NDA Data Sharing Terms and Conditions.  Additionally, Supporting Documentation uploaded to a Collection may be shared independent of whether data are shared, but will only be viewable and accessible if the Collection is Shared.

NDA Help Center

fMRi

fMRI stands for functional magnetic resonance imaging. fMRI tests measure blood flow, providing detailed functional images of the brain or body. 

Acquisition
The Acquisition parameters needed for an experiment include the following:

The name of the experiment is required. Please be concise and specific as possible.
Following experiment name, selection boxes are provided for the Equipment, Software, or other items specific to the experiment type. At least one selection is required for each. If NDAR does not have the appropriate listing, select Add New to add the information provided. Following the selection boxes, provide additional information may be required depending on the experiment type. Any required items are denoted by an asterisk (*).

Block/Event Design
At least one block/event is required. Note that any fields denoted with an asterisk (*) are required. All data must be devoid of personally identifiable data, including the contents of any files attached to the experiment.

Note: To simplify the definition of multiple events, we provide an Import from XML function. This function supports importing data from all three experiment sections (Acquisition, Block/Event Design, and Post Processing), at this time files cannot be uploaded from XML A test format is provided here and our XML Schema Definition (xsd) can be found here.

Post Processing
If you have completed any post-processing on your data, please choose 'Yes' for Has Postprocessing? If not, select 'No'. Depending on this selection the remaining post-processing fields will be enabled (some of which will be required). If you are initially providing data you can select 'No', then return to the experiment to add post-processing steps at a later date when the data are being provided.

Please provide information about post-processing manipulations, i.e. artifact detection algorithms, segmentation used for post data collection, items denoted with an asterisk (*) are required.

Frequently Asked Questions

Glossary

  • This button will add all selections to the Filter Cart. 

  • This button will allow you to copy all of the Experiment details as a template for a new experiment. 

  • Adds all data from the current selections in a Collection or NDA Study to the Filter Cart.

  • This button will allow you to return to the Experiments tab. 

NDA Help Center

Collection - Submissions Tab

Users with permission to access Shared data in the Collection’s assigned Permission Group may use this tab. 

Here, you can:

  • Review your uploads to your Collection, monitor their status, and download them individually to verify their contents.
  • Download individual datasets as a secondary user of the data approved for access.
  • Identify and download datasets containing errors identified by NDA's QA/QC process for review and resolution.
  • Report suspected or discovered Personally Identifiable Information in a submission via the Actions column.

Frequently Asked Questions

Glossary

  • The default view of Datasets within a Collection's Submission tab.

  • A Submission Loading Status on a Collection's Submission Tab that indicates that an issue has prevented the successful loading of the submission.  Users should contact the NDA Help Desk for assistance at NDAHelp@mail.nih.gov.

  • The NDA has two Submission Cycles per year - January 15 and July 15.

  • An interface to notify NDA that data may not be submitted during the upcoming/current submission cycle.  

  • The unique and sequentially assigned ID for a submission (e.g. a discrete upload via the Validation and Upload Tool), which may contain any number of datafiles, Data Structures and/or Data Types, regardless of the Submission Loading Status. A single submission may be divided into multiple Datasets, which are based on Data Type.

  • The total number of unique subjects for whom data have been shared and are available for users with permission to access data.

  • The total number of unique subjects for whom data have been submitted, which includes data in both a Private State and a Shared State.

NDA Help Center

Collection - Publications Tab

The number of Publications is displayed in parentheses next to the tab name. Clicking on any of the Publication Titles will open the Publication in a new internet browsing tab. 

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may mark a publication as either Relevant or Not Relevant in the Status column. 

 

Frequently Asked Questions

  • Publications are considered relevant to a collection when the data shared is directly related to the project or collection.

  • PubMed, an online library containing journals, articles, and medical research. Sponsored by NiH and National Library of Medicine (NLM). 

Glossary

  • A link to the Create an NDA Study page that can be clicked to start creating an NDA Study with information such as the title, journal and authors automatically populated.

  • Indicates that the publication has not yet been reviewed and/or marked as Relevant or Not Relevant so it has not been determined whether an NDA Study is expected.

  • A publication that is not based on data related to the aims of the grant/project associated with the Collection or not based on any data such as a review article and, therefore, an NDA Study is not expected to be created.

  • PubMed provides citation information for biomedical and life sciences publications and is managed by the U.S. National Institutes of Health's National Library of Medicine.

  • The PUBMed ID is the unique ID number for the publication as recorded in the PubMed database.  

  • A publication that is based on data related to the aims of the grant/project associated with the Collection and, therefore, an NDA Study is expected to be created.

NDA Help Center

EEG

EEG stands for electroencencephalogram and is a test used to measure electrical activity in the brain.

Acquisition
The Acquisition parameters needed for an experiment include the following:

Name of the experiment is required. Please be concise and specific as possible.
Following experiment name, selection boxes are provided for the Equipment, Software, or other items specific to experiment type. At least one selection is required for each. If NDAR does not have the appropriate listing, select Add New to add the information provided. Following the selection boxes, provide additional information may be required depending on experiment type. Any required items are denoted by an asterisk (*).

Block/Event Design
At least one block/event is required. Note that any fields denoted with an asterisk (*) are required. All data must be devoid of personally identifiable data, including the contents of any files attached to the experiment.

Note: To simplify definition of multiple events, we provide an Import from XML function. This function supports importing data from all three experiment sections (Acquisition, Block/Event Design, and Post Processing), at this time files cannot be uploaded from XML A test format is provided here and our XML Schema Definition (xsd) can be found here.

Post Processing
If you have completed any post processing on your data, please choose 'Yes' for Has Postprocessing? If not, select 'No'. Depending on this selection the remaining post processing fields will be enabled (some of which will be required). If you are initially providing data you can select 'No', then return to the experiment to add post processing steps at a later date when the data are being provided.

Please provide information about post-processing manipulations, i.e. artifact detection algorithms, segmentation used for post data collection, items denoted with an asterisk (*) are required.

Frequently Asked Questions

Glossary

  • This button will add all selections to the Filter Cart. 

  • This button will allow you to copy all of the Experiment details as a template for a new experiment. 

  • Adds all data from the current selections in a Collection or NDA Study to the Filter Cart.

  • This button will allow you to return to the Experiments tab. 

NDA Help Center

Collection - Data Expected

The Data Expected tab displays the list of all data that NDA expects to receive in association with the Collection as defined by the contributing researcher, as well as the dates for the expected initial upload of the data, and when it is first expected to be shared, or with the research community. Above the primary table of Data Expected, any publications determined to be relevant to the data within the Collection are also displayed - members of the contributing research group can use these to define NDA Studies, connecting those papers to underlying data in NDA.

The tab is used both as a reference for those accessing shared data, providing information on what is expected and when it will be shared, and as the primary tracking mechanism for contributing projects. It is used by both contributing primary researchers, secondary researchers, and NIH Program and Grants Management staff.

Contributing researchers just getting started on their project will need to define this list by adding all of the items they are collecting under their grant and setting their schedule according to the NDA Data Sharing Regimen. If you fall into this category, you can begin by clicking "add new Data Expected" and selecting which data structures you will be using, saving the page after each change, or requesting new structures by adding and naming a new item, providing any materials NDA Data Dictionary Curators can use to help define your structure. For more information see the tutorial on creating Data Expected.

If you are a contributing researcher creating this list for the first time, or making changes to the list as your project progress, please note the following:

  • Although items you add to the list and changes you make are displayed, they are not committed to the system until you Save the entire page using the "Save" button at the bottom of your screen. Please Save after every change to ensure none of your work is lost.
  • If you attempt to add a new structure, the title you provide must be unique - if another structure exists with the same name your change will fail.
  • Adding a new structure to this list is the only way to request the creation of a new Data Dictionary definition.

 

Frequently Asked Questions

  • An NDA Data Structure is comprised of multiple Data Elements to make up an electronic definition of an assessment, measure, questionnaire, etc will have a corresponding Data Structure.

  • The NDA Data Dictionary is comprised of electronic definitions known as Data Structures.

Glossary

  • Data specific to the primary aims of the research being conducted (e.g. outcome measures, other dependent variables, observations, laboratory results, analyzed images, volumetric data, etc.) including processed images.

  • Items listed on the Data Expected list in the Collection which may be an individual and discrete Data Structure, Data Structure Category, or Data Structure Group.

  • A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure

  • An NDA term describing the affiliation of a Data Structure to a Category, which may be disease/disorder or diagnosis related (Depression, ADHD, Psychosis), specific to data type (MRI, eye tracking, omics), or type of data (physical exam, IQ).

  • A Data Item listed on the Data Expected tab of a Collection that indicates a group of Data Structures (e.g., ADOS or SCID) for which data may be submitted instead of a specific Data Structure identified by version, module, edition, etc. For example, the ADOS Data Structure Category includes every ADOS Data Structure such as ADOS Module 1, ADOS Module 2, ADOS Module 1 - 2nd Edition, etc. The SCID Data Structure Group includes every SCID Data Structure such as SCID Mania, SCID V Mania, SCID PTSD, SCID-V Diagnosis, and more. 

  • A new Data Structure category, Evaluated Data is analyzed data resulting from the use of computational pipelines in the Cloud and can be uploaded directly back to a miNDAR database.  Evaluated Data is expected to be listed as a Data Item in the Collection's Data Expected Tab.

  • Imaging+ is an NDA term which encompasses all imaging related data including, but not limited to, images (DTI, MRI, PET, Structural, Spectroscopy, etc.) as well as neurosignal data (EEG, fMRI, MEG, EGG, eye tracking, etc.) and Evaluated Data.

  • Initial Submission and Initial Share dates should be populated according to the NDA Data Sharing Terms and Conditions. Any modifications to these will go through the approval processes outlined above. Data will be shared with authorized users upon publication (via an NDA Study) or 1-2 years after the grant end date specified on the first Notice of Award, as defined in the applicable Data Sharing Terms and Conditions.

  • Initial Submission and Initial Share dates should be populated according to these NDA Data Sharing Terms and Conditions. Any modifications to these will go through the approval processes outlined above. Data for all subjects is not expected on the Initial Submission Date and modifications may be made as necessary based on the project's conduct.

  • An NDA created Data Structure used to convey basic information about the subject such as demographics, pedigree (links family GUIDs), diagnosis/phenotype, and sample location that are critical to allow for easier querying of shared data.

  • The NDA has two Submission Cycles per year - January 15 and July 15.

  • An interface to notify NDA that data may not be submitted during the upcoming/current submission cycle.  

NDA Help Center

Collection - Permissions

Collection Owners, Program Officers, and users with Administrator privileges may view this tab.

The available permission groups include:

  • Query: This read-only access is generally for NIH Program Officers
  • Submission: This will grant read access and allow the user to upload data and create experiment definitions. This is for the typical contributing personnel member.
  • Administrator: In addition to the access provided to Query and Submission users, Admins can also edit the Collection itself, create or edit the Data Expected list, and edit user permissions. This access is for the PI, data managers, and anyone they wish to delegate this to.

The PI has a special designation as the Collection Owner in addition to administrator access.

Frequently Asked Questions

  • Collection Owners and Admins may assign Collection Privileges to anyone.

  • Yes, you can assign various Privileges to other users with an NDA account.

  • If you are the Collection Owner or have Admin privileges, you can view and make changes to the list of individuals who have access to the Collection on the Collection's Permissions tab.  Information on users who have access to data Shared in your Collection because they were granted access to a Permission Group is not available.

  • Staff/collaborators who are working submitting data to the Collection, checking the quality of the data, and/or analyzing data should have access for the duration of the project until all data have been submitted, NDA Studies have been created for data used in publications, and/or a collaborative relationship with the user exists.  

  • The individual listed as an Investigator on the General tab of the NDA Collection will generally be able to provide a user access to the NDA Collection.  Additional users may also have this ability if granted Administrator access to an NDA Collection; however, these users are not viewable unless your account has access to the NDA Collection.  Given this, it is best to contact the Investigator to request access to the Collection.

  • Privileges that can be assigned to a user include:
    Submission allows a user to submit data to Collection
    Query allows the user to download data from Collection even when in a Private state
    Admin is both the Submission and Query Privilege + the ability to give privileges to other users.

  • You may have staff who are working on the submission of data or other activities associated with data sharing such as the definition of the Data Expected list or NDA Experiment creation.  Also, many projects have multiple performance sites and wish to share data among the site PIs.  Submitting to the NDA facilitates access by all investigators working on a project even before data have been shared with other users.  You can control who gets access to data while in a Private state.

Glossary

  • A privilege provided to a user associated with an NDA Collection or NDA Study whereby that user can perform a full range of actions including providing privileges to other users. 

  • Access to shared record-level data in NDA is provisioned at the level of a Permission Group. NDA Permission Groups consist of one or multiple NDA Collections that contain data with the same subject consents.

NDA Help Center

Eye Tracking

EyeTracking tests follow the movement of the eye. The visual trajectory or focus can help determine predictions and assist in diagnoses. 

Acquisition
The Acquisition parameters needed for an experiment include the following:

The name of the experiment is required. Please be concise and specific as possible.
Following experiment name, selection boxes are provided for the Equipment, Software, or other items specific to the experiment type. At least one selection is required for each. If NDAR does not have the appropriate listing, select Add New to add the information provided. Following the selection boxes, provide additional information may be required depending on the experiment type. Any required items are denoted by an asterisk (*).

Block/Event Design
At least one block/event is required. Note that any fields denoted with an asterisk (*) are required. All data must be devoid of personally identifiable data, including the contents of any files attached to the experiment.

Note: To simplify the definition of multiple events, we provide an Import from XML function. This function supports importing data from all three experiment sections (Acquisition, Block/Event Design, and Post Processing), at this time files cannot be uploaded from XML A test format is provided here and our XML Schema Definition (xsd) can be found here.

Post Processing
If you have completed any post-processing on your data, please choose 'Yes' for Has Postprocessing? If not, select 'No'. Depending on this selection the remaining post-processing fields will be enabled (some of which will be required). If you are initially providing data you can select 'No', then return to the experiment to add post-processing steps at a later date when the data are being provided.

Please provide information about post-processing manipulations, i.e. artifact detection algorithms, segmentation used for post data collection, items denoted with an asterisk (*) are required.

Frequently Asked Questions

Glossary

  • This button will add all selections to the Filter Cart. 

  • This button will allow you to copy all of the Experiment details as a template for a new experiment. 

  • Adds all data from the current selections in a Collection or NDA Study to the Filter Cart.

  • This button will allow you to return to the Experiments tab. 

NDA Help Center

Collection - Experiments Tab

The number of Experiments included is displayed in parentheses next to the tab name. You may download all experiments associated with the Collection via the Download button. You may view individual experiments by clicking the Experiment Name and add them to the Filter Cart via the Add to Cart button.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may create or edit an Experiment.

Please note: The creation of an NDA Experiment does not necessarily mean that data collected, according to the defined Experiment, has been submitted or shared.

Frequently Asked Questions

  • Yes -see the “Copy” button in the bottom left when viewing an experiment. There are two actions that can be performed via this button:

    1. Copy the experiment with intent for modifications.  
    2. Associate the experiment to the collection. No modifications can be made to the experiment.

     

Glossary

  • An Experiment must be Approved before data using the associated Experiment_ID may be uploaded.

  • The ID number automatically generated by NDA which must be included in the appropriate file when uploading data to link the Experiment Definition to the subject record.

NDA Help Center

Omics

Omics is a collective group of technologies, related to a field of study in Biology such as Genomics or proteomics. 

Experiment Parameters

To define an Omics experiment, provide a meaningful name and select a single molecule. The standard molecules are listed. However, if you are doing proteomic or environmental experiments, simply “Add New” and the new selection will be created. Only one value for molecule is permitted.

Next the technology (box 2) associated with the molecule will be presented along with its application. Again, only one selection is possible. If you wish to see all of NDAR’s options for any one box, Select “Show All”.

Platform

Continue to select the Platform (box 3).

Extraction

Next, the Extraction Protocol (box 4) and Kits (box 5) are presented based upon the Molecule selected and the Processing Protocol (box 6) and Kits (box 7) are presented based upon the Molecule and Technology Application (Box 1 and 2)

Processing

Note that for each of these (boxes 4, 5, 6, and 7) multiple selections are possible.

Additional Information

Lastly, the Software (box 8) and Equipment (box 9) is expected.

 

Once saved, the experiment will be associated with the Collection and by using the returned Experiment_ID, the NDA makes it possible to associate the experiment meta data directly with the data from the experiment.

Frequently Asked Questions

Glossary

  • This button will add all selections to the Filter Cart. 

  • This button will allow you to copy all of the Experiment details as a template for a new experiment. 

  • Adds all data from the current selections in a Collection or NDA Study to the Filter Cart.

  • This button will allow you to return to the Experiments tab. 

NDA Help Center

Collection - Associated Studies

Clicking on the Study Title will open the study details in a new internet browser tab. The Abstract is available for viewing, providing the background explanation of the study, as provided by the Collection Owner. 

Primary v. Secondary Analysis: The Data Usage column will have one of these two choices. An associated study that is listed as being used for Primary Analysis indicates at least some and potentially all of the data used was originally collected by the creator of the NDA Study. Secondary Analysis indicates the Study owner was not involved in the collection of data, and may be used as supporting data. 

Private v. Shared State: Studies that remain private indicate the associated study is only available to users who are able to access the collection. A shared study is accessible to the general public. 

Frequently Asked Questions

  • Studies are associated to the Collection automatically when the data is defined in the Study. 

Glossary

  • A tab in a Collection that lists the NDA Studies that have been created using data from that Collection including both Primary and Secondary Analysis NDA Studies.

Loading...

National Institute of Mental Health Data Archive (NDA) Sign In
National Institute of Mental Health Data Archive (NDA) Sign In
NDA

Success! An email is on its way!

Please check your email to complete the linking process. The link you receive is only valid for 30 minutes.

Check your spam or junk folder if you do not receive the email in the next few minutes.

Warning Notice This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.
Create an Account
NIMH Data Archive (NDA) Sign In or Create An Account
Update Password

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

  • Uppercase
  • Lowercase
  • Numbers
  • Special Characters limited to: %,_,!,@,#,$,-,%,&,+,=,),(,*,^,:,;

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the NIMH Data Archive (NDA) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDA is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Accept Terms
Data Access Terms - Decline Terms

Are you sure you want to cancel? This will decline terms and you will not be authorized for access.

Filter Cart
No filters selected
Description
Value Range
Notes
Data Structures with shared data
No filters have been selected
Switch User

1 Numbers reported are subjects by age
New Trial
New Project

Format should be in the following format: Activity Code, Institute Abbreviation, and Serial Number. Grant Type, Support Year, and Suffix should be excluded. For example, grant 1R01MH123456-01A1 should be entered R01MH123456

Please select an experiment type below

Collection - Use Existing Experiment

To associate an experiment to the current collection, just select an axperiment from the table below then click the associate experiment button to persist your changes (saving the collection is not required). Note that once an experiment has been associated to two or more collections, the experiment will not longer be editable.

The table search feature is case insensitive and targets the experiment id, experiment name and experiment type columns. The experiment id is searched only when the search term entered is a number, and filtered using a startsWith comparison. When the search term is not numeric the experiment name is used to filter the results.

SelectExperiment IdExperiment NameExperiment Type
Created On
24HI-NGS_R1Omics02/16/2011
475MB1-10 (CHOP)Omics06/07/2016
490Illumina Infinium PsychArray BeadChip AssayOmics07/07/2016
501PharmacoBOLD Resting StatefMRI07/27/2016
506PVPREFOmics08/05/2016
509ABC-CT Resting v2EEG08/18/2016
13Comparison of FI expression in Autistic and Neurotypical Homo SapiensOmics12/28/2010
18AGRE/Broad Affymetrix 5.0 Genotype ExperimentOmics01/06/2011
22Stitching PCR SequencingOmics02/14/2011
26ASD_MethylationOmics03/01/2011
29Microarray family 03 (father, mother, sibling)Omics03/24/2011
37Standard paired-end sequencing of BCRsOmics04/19/2011
38Illumina Mate-Pair BCR sequencingOmics04/19/2011
39Custom Jumping LibrariesOmics04/19/2011
40Custom CapBPOmics04/19/2011
41ImmunofluorescenceOmics05/11/2011
43Autism brain sample genotyping, IlluminaOmics05/16/2011
47ARRA Autism Sequencing Collaboration at Baylor. SOLiD 4 SystemOmics08/01/2011
53AGRE Omni1-quadOmics10/11/2011
59AGP genotypingOmics04/03/2012
60Ultradeep 454 sequencing of synaptic genes from postmortem cerebella of individuals with ASD and neurotypical controlsOmics06/23/2012
63Microemulsion PCR and Targeted Resequencing for Variant Detection in ASDOmics07/20/2012
76Whole Genome Sequencing in Autism FamiliesOmics01/03/2013
519RestingfMRI11/08/2016
90Genotyped IAN SamplesOmics07/09/2013
91NJLAGS Axiom Genotyping ArrayOmics07/16/2013
93AGP genotyping (CNV)Omics09/06/2013
106Longitudinal Sleep Study. H20 200. Channel set 2EEG11/07/2013
107Longitudinal Sleep Study. H20 200. Channel set 3EEG11/07/2013
108Longitudinal Sleep Study. AURA 200EEG11/07/2013
105Longitudinal Sleep Study. H20 200. Channel set 1EEG11/07/2013
109Longitudinal Sleep Study. AURA 400EEG11/07/2013
116Gene Expression Analysis WG-6Omics01/07/2014
131Jeste Lab UCLA ACEii: Charlie Brown and Sesame Street - Project 1Eye Tracking02/27/2014
132Jeste Lab UCLA ACEii: Animacy - Project 1Eye Tracking02/27/2014
133Jeste Lab UCLA ACEii: Mom Stranger - Project 2Eye Tracking02/27/2014
134Jeste Lab UCLA ACEii: Face Emotion - Project 3Eye Tracking02/27/2014
145AGRE/FMR1_Illumina.JHUOmics04/14/2014
146AGRE/MECP2_Sanger.JHUOmics04/14/2014
147AGRE/MECP2_Junior.JHUOmics04/14/2014
151Candidate Gene Identification in familial AutismOmics06/09/2014
152NJLAGS Whole Genome SequencingOmics07/01/2014
154Math Autism Study - Vinod MenonfMRI07/15/2014
155RestingfMRI07/25/2014
156SpeechfMRI07/25/2014
159EmotionfMRI07/25/2014
160syllable contrastEEG07/29/2014
167School-age naturalistic stimuliEye Tracking09/19/2014
44AGRE/Broad Affymetrix 5.0 Genotype ExperimentOmics06/27/2011
45Exome Sequencing of 20 Sporadic Cases of Autism Spectrum DisorderOmics07/15/2011
Collection - Add Experiment
Add Supporting Documentation
Select File

Please enter the name of the data structure to search or if your definition does not exist, please upload that definition so that it can be appropriately defined for submission. Multiple data structures may be associated with a single Data Expected entry. Please add only one data structure per assessment.

Request Submission Exemption
Characters Remaining:
Not Eligible

The Data Expected list for this Collection shows some raw data as missing. Contact the NDA Help Desk with any questions.

Please confirm that you will not be enrolling any more subjects and that all raw data has been collected and submitted.

Collection Updated

Your Collection is now in Data Analysis phase and exempt from biannual submissions. Analyzed data is still expected prior to publication or no later than the project end date.

[CMS] Attention
[CMS] Please confirm that you will not be enrolling any more subjects and that all raw data has been collected and submitted.
[CMS] Error

[CMS]

Unable to change collection phase where targeted enrollment is less than 90%

Delete Submission Exemption
Are you sure you want to delete this submission exemption?
You have requested to move the sharing dates for the following assessments:
Data Expected Item Original Sharing Date New Sharing Date

Please provide a reason for this change, which will be sent to the Program Officers listed within this collection:

Explanation must be between 20 and 200 characters in length.

Please press Save or Cancel
Add New Email Address - Dialog
New Email Address
Shared
Collection Summary Collection Charts
Collection Title Collection Investigators Collection Description
The CHARGE Study: Childhood Autism Risks From Genetics and the Environment
Irva Hertz-Picciotto 
Few rigorous epidemiologic studies have addressed the environmental causes and biologic underpinnings of autism spectrum disorder (ASD). The CHARGE (CHildhood Autism Risks from Genetics and Environment) Study is a large, population-based case-control investigation of environmental risk factors, broadly defined, in relation to ASD and developmental delay without ASD symptoms, with referents from the general population.Fieldwork began In 2003, and by now CHARGE has published widely on exposures such as air pollution,mercury, flame retardants, maternal nutritional status in the peri-conception, untreated fever during pregnancy,mitochondrial dysfunction, candidate genes, a wide array of functional immune markers in both the child and the mother, and maternal metabolic conditions including obesity and diabetes. This last finding is notable, given the epidemic of obesity and type 2 diabetes that has occurred in parallel with the steady rise in ASD over the last few decades. Moreover, an emerging literature implicates several endocrine disrupting chemicals as contributing to obesity and metabolic dysregulation, including hyper insulinemia, and to neurodevelopmental disorders as well. This project therefore builds upon these observations in several ways.First, obesity and type 2 or gestational diabetes will be examined in a larger sample, and glucose challenge test (GCT) results for the first time, to determine associations not only with development of ASD and intellectual impairment in the children, but also with specific speech and language delays, behavioral phenotypes such as attention deficits or hyperactivity, and gene expression. Second, these maternal metabolic conditions will be evaluated for associations with markers of both metabolic and immune dysregulation to be measured in neonatal blood spots. Third, the predictive value of neonatal bloodspot markers for a later diagnosis of ASD or other child developmental and behavioral outcomes will be assessed. Fourth, the maternal metabolic conditions will be analyzed for potential links with upstream exposures to phthalates and antibacterial compounds, ubiquitous chemicals in common household products. Finally, this project will examine how gene variants that play a role in biochemical pathways relevant to the processes under study may influence susceptibility of the mother, the neonate or the child. To ensure adequate power for this analysis of gene-environment interaction, the sample size will be increased to 2400 children. This project addresses several goals set by the NIH Interagency Autism Coordinating Committee: 1) to discover environmental factors contributing to ASD, particularly in the prenatal period, 2) to understand biological mechanisms for ASD risk,including gene-by-environment interactions, and 3) to identify children at risk for ASD at earlier time points.Results of this detailed inquiry into early exposures, maternal pathophysiology and prognostic markers in the newborn will set the stage for developing prevention strategies.
NIMH Data Archive
10/30/2013
Funding Completed
Close Out
Shared
No
$4,624,873.00
602
Loading Chart...
NIH - Extramural None

QA-notification.txt Other Quality Assurance Notification Qualified Researchers

R01ES015359-01 The Charge Study: Childhood Autism Risks from Genetics and the Environment 02/08/2007 01/31/2012 5608 5501 UNIVERSITY OF CALIFORNIA AT DAVIS $2,146,125.00
R01ES015359-06 THE CHARGE STUDY: CHILDHOOD AUTISM RISKS FROM GENETICS AND THE ENVIRONMENT 08/19/2013 06/30/2018 7900 7874 UNIVERSITY OF CALIFORNIA AT DAVIS $2,478,748.00

helpcenter.collection.general-tab

NDA Help Center

Collection - General

Fields available for edit on the top portion of the page include:

  • Collection Title
  • Investigators
  • Collection Description
  • Collection Phase
  • Funding Source
  • Clinical Trials

Collection Status: The visibility status of an NDA Collection. Collection Status can be Shared or Private. Collections in Shared status are visible to all users and can be searched in the NDA Query Tool. Private Collections are not visible to NDA users. The Status of an NDA Collection only affects the visibility of information about the Collection (metadata) and does not relate to the status of the record-level research data in the NDA Collection.

Collection Phase: The current status of a research project submitting data to an NDA Collection, based on the timing of the award and/or the data that have been submitted.

  • Pre-Enrollment: The default entry made when the NDA Collection is created.
  • Enrolling: Data have been submitted to the NDA Collection or the NDA Data Expected initial submission date has been reached for at least one data structure category in the NDA Collection.
  • Data Analysis: Subject level data collection for the research project is completed and has been submitted to the NDA Collection. The NDA Collection owner or the NDA Help Desk may set this phase when they’ve confirmed data submission is complete and submitted subject counts match at least 90% of the target enrollment numbers in the NDA Data Expected. Data submission reminders will be turned off for the NDA Collection.
  • Funding Completed: The NIH grant award (or awards) associated with the NDA Collection has reached its end date. NDA Collections in Funding Completed phase are assigned a subphase to indicate the status of data submission.
    • The Data Expected Subphase indicates that NDA expects more data will be submitted
    • The Closeout Subphase indicates the data submission is complete.
    • The Sharing Not Met Subphase indicates that data submission was not completed as expected.

Blinded Clinical Trial Status:

  • This status is set by a Collection Owner and indicates the research project is a double blinded clinical trial. When selected, the public view of Data Expected will show the Data Expected items and the Submission Dates, but the targeted enrollment and subjects submitted counts will not be displayed.
  • Targeted enrollment and subjects submitted counts are visible only to NDA Administrators and to the NDA Collection or as the NDA Collection Owner.
  • When an NDA Collection that is flagged Blinded Clinical Trial reaches the maximum data sharing date for that Data Repository (see https://nda.nih.gov/about/sharing-regimen.html), the embargo on Data Expected information is released.

Funding Source

The organization(s) responsible for providing the funding is listed here.

Supporting Documentation

Users with Submission privileges, as well as Collection Owners, Program Officers, and those withAdministrator privileges, may upload and attach supporting documentation. By default, supporting documentation is shared to the general public, however, the optionis also available tolimit this information to qualified researchers only.

Grant Information

Identifiable details are displayed about the Project of which the Collection was derived from. You may click in the Project Number to view a full report of the Project capturedby the NIH.

Clinical Trials

Any data that is collected to support or further the research of clinical studies will be available here. Collection Owners and those with Administrator privileges may add new clinical trials.

Frequently Asked Questions

  • How do I know when a NDA Collection has been created?
    When a Collection is created by NDA staff and marked as Shared, an email notification will automatically be sent to the PI(s) of the grant(s) associated with the Collection to notify them.
  • How does the NIMH Data Archive (NDA) determine which Permission Group data are submitted into?
    During Collection creation, NDA staff determine the appropriate Permission Group based on the type of data to be submitted, the type of access that will be available to data access users, and the information provided by the Program Officer during grant award.
  • Is a single grant number ever associated with more than one Collection?
    The NDA system does not allow for a single grant to be associated with more than one Collection; therefore, a single grant will not be listed in the Grant Information section of a Collection for more than one Collection.
  • Why is there sometimes more than one grant included in a Collection?
    In general, each Collection is associated with only one grant; however, multiple grants may be associated if the grant has multiple competing segments for the same grant number or if multiple different grants are all working on the same project and it makes sense to hold the data in one Collection (e.g., Cooperative Agreements).

Glossary

  • Actual Enrollment
    Number of human subjects enrolled in an NIH-funded clinical research study. The data is provided in annual progress reports.
  • Administrator Privilege
    A privilege provided to a user associated with an NDA Collection or NDA Study whereby that user can perform a full range of actions including providing privileges to other users.
  • Collection Owner
    Generally, the Collection Owner is the contact PI listed on a grant. Only one NDA user is listed as the Collection owner. Most automated emails are primarily sent to the Collection Owner.
  • Data Use Limitations
    Data Use Limitations (DULs) describe the appropriate secondary use of a dataset and are based on the original informed consent of a research participant. NDA only accepts consent-based data use limitations defined by the NIH Office of Science Policy.
  • Grant
    Provides the grant number(s) for the grant(s) associated with the Collection. The field is a hyperlink so clicking on the Grant number will direct the user to the grant information in the NIH Research Portfolio Online Reporting Tools (RePORT) page.
  • NDA Collection
    A virtual container and organization structure for data and associated documentation from one grant or one large project/consortium. It contains tools for tracking data submission and allows investigators to define a wide array of other elements that provide context for the data, including all general information regarding the data and source project, experimental parameters used to collect any event-based data contained in the Collection, methods, and other supporting documentation. They also allow investigators to link underlying data to an NDA Study, defining populations and subpopulations specific to research aims.
  • Permission Group
    Access to shared record-level data in NDA is provisioned at the level of a Permission Group. NDA Permission Groups consist of one or multiple NDA Collections that contain data with the same subject consents.
  • Collection Phase
    The Collection Phase provides information on data submission as opposed to grant/project completion so while the Collection phase and grant/project phase may be closely related they are often different. Collection users with Administrative Privileges are encouraged to edit the Collection Phase. The Program Officer as listed in eRA (for NIH funded grants) may also edit this field. Changes must be saved by clicking the Save button at the bottom of the page. This field is sortable alphabetically in ascending or descending order. Collection Phase options include:
    • Pre-Enrollment: A grant/project has started, but has not yet enrolled subjects.
    • Enrolling: A grant/project has begun enrolling subjects. Data submission is likely ongoing at this point.
    • Data Analysis: A grant/project has completed enrolling subjects and has completed all data submissions.
    • Funding Completed: A grant/project has reached the project end date.
  • Planned Enrollment
    Number of human subject participants to be enrolled in an NIH-funded clinical research study. The data is provided in competing applications and annual progress reports.
  • NIH Research Initiative
    NDA Collections may be organized by scientific similarity into NIH Research Initiatives, to facilitate query tool user experience. NIH Research Initiatives map to one or multiple Funding Opportunity Announcements.
  • Collection State
    The Collection State indicates whether the Collection is viewable and searchable. Collections can be either Private, Shared, or an Ongoing Study. A Collection that is shared does not necessarily have shared data as the Collection State and state of data are independent of each other. This field can be edited by Collection users with Administrative Privileges and the Program Officer as listed in eRA (for NIH funded grants). Changes must be saved by clicking the Save button at the bottom of the page.
  • Supporting Documentation
    Various documents and materials to enable efficient use of the data by investigators unfamiliar with the project and may include the research protocol, questionnaires, and study manuals.
  • Collection Title
    An editable field with the title of the Collection, which is often the title of the grant associated with the Collection.
  • Total Subjects Shared
    The total number of unique subjects for whom data have been shared and are available for users with permission to access data.
IDNameCreated DateStatusType
No records found.
helpcenter.collection.experiments-tab

NDA Help Center

Collection - Experiments

The number of Experiments included is displayed in parentheses next to the tab name. You may download all experiments associated with the Collection via the Download button. You may view individual experiments by clicking the Experiment Name and add them to the Filter Cart via the Add to Cart button.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may create or edit an Experiment.

Please note: The creation of an NDA Experiment does not necessarily mean that data collected, according to the defined Experiment, has been submitted or shared.

Frequently Asked Questions

  • Can an Experiment be associated with more than one Collection?

    Yes -see the “Copy” button in the bottom left when viewing an experiment. There are two actions that can be performed via this button:

    1. Copy the experiment with intent for modifications.
    2. Associate the experiment to the collection. No modifications can be made to the experiment.

Glossary

  • Experiment Status
    An Experiment must be Approved before data using the associated Experiment_ID may be uploaded.
  • Experiment ID
    The ID number automatically generated by NDA which must be included in the appropriate file when uploading data to link the Experiment Definition to the subject record.

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Shared Data

Data structures with the number of subjects submitted and shared are provided.

Aberrant Behavior Checklist (ABC) - Community Clinical Assessments 545
Autism Diagnostic Interview, Revised (ADI-R) Clinical Assessments 378
Autism Diagnostic Observation Schedule (ADOS) - Module 1 (2007) Clinical Assessments 64
Autism Diagnostic Observation Schedule (ADOS) - Module 2 (2007) Clinical Assessments 42
Autism Diagnostic Observation Schedule (ADOS)- Module 3 (2007) Clinical Assessments 5
Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2) - Module 1 Clinical Assessments 130
Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2) - Module 2 Clinical Assessments 97
Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2) - Module 3 Clinical Assessments 5
CHARGE Physical Exam Clinical Assessments 366
Demographics Clinical Assessments 552
Early Development Questionnaire Clinical Assessments 498
Gastrointestinal History Clinical Assessments 549
Mullen Scales of Early Learning Clinical Assessments 551
Parent Chemical or Substance Exposure Clinical Assessments 538
Research Subject Clinical Assessments 551
Sleep History Clinical Assessments 549
Social Communication Questionnaire (SCQ) - Lifetime Clinical Assessments 227
Vineland I Clinical Assessments 595
helpcenter.collection.shared-data-tab

NDA Help Center

Collection - Shared Data

This tab provides a quick overview of the Data Structure title, Data Type, and Number of Subjects that are currently Shared for the Collection. The information presented in this tab is automatically generated by NDA and cannot be edited. If no information is visible on this tab, this would indicate the Collection does not have shared data or the data is private.

The shared data is available to other researchers who have permission to access data in the Collection's designated Permission Group(s). Use the Download button to get all shared data from the Collection to the Filter Cart.

Frequently Asked Questions

  • How will I know if another researcher uses data that I shared through the NIMH Data Archive (NDA)?
    To see what data your project have submitted are being used by a study, simply go the Associated Studies tab of your collection. Alternatively, you may review an NDA Study Attribution Report available on the General tab.
  • Can I get a supplement to share data from a completed research project?
    Often it becomes more difficult to organize and format data electronically after the project has been completed and the information needed to create a GUID may not be available; however, you may still contact a program staff member at the appropriate funding institution for more information.
  • Can I get a supplement to share data from a research project that is still ongoing?
    Unlike completed projects where researchers may not have the information needed to create a GUID and/or where the effort needed to organize and format data becomes prohibitive, ongoing projects have more of an opportunity to overcome these challenges. Please contact a program staff member at the appropriate funding institution for more information.

Glossary

  • Data Structure
    A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure
  • Data Type
    A grouping of data by similar characteristics such as Clinical Assessments, Omics, or Neurosignal data.
  • Shared
    The term 'Shared' generally means available to others; however, there are some slightly different meanings based on what is Shared. A Shared NDA Collection or NDA Study is viewable and searchable publicly regardless of the user's role or whether the user has an NDA account. A Shared Collection or NDA Study does not necessarily mean that data submitted to the Collection or used in the NDA Study have been shared as this is independently determined. Data are shared according the schedule defined in a Collection's Data Expected Tab and/or in accordance with data sharing expectations in the NDA Data Sharing Terms and Conditions. Additionally, Supporting Documentation uploaded to a Collection may be shared independent of whether data are shared, but will only be viewable and accessible if the Collection is Shared.

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Publications

Publications relevant to NDA data are listed below. Most displayed publications have been associated with the grant within Pubmed. Use the "+ New Publication" button to add new publications. Publications relevant/not relevant to data expected are categorized. Relevant publications are then linked to the underlying data by selecting the Create Study link. Study provides the ability to define cohorts, assign subjects, define outcome measures and lists the study type, data analysis and results. Analyzed data and results are expected in this way.

PubMed IDStudyTitleJournalAuthorsDateStatus
36144233Create StudyMaternal Serum and Placental Metabolomes in Association with Prenatal Phthalate Exposure and Neurodevelopmental Outcomes in the MARBLES Cohort.MetabolitesParenti, Mariana; Schmidt, Rebecca J; Ozonoff, Sally; Shin, Hyeong-Moo; Tancredi, Daniel J; Krakowiak, Paula; Hertz-Picciotto, Irva; Walker, Cheryl K; Slupsky, Carolyn MSeptember 2, 2022Not Determined
35943360Create StudyPilot Study of Maternal Autoantibody-Related Autism.Journal of developmental and behavioral pediatrics : JDBPAngkustsiri, Kathleen; Fussell, Jill J; Bennett, Amanda; Schauer, Joseph; Ramirez-Celis, Alexandra; Hansen, Robin L; Van de Water, JudyOctober 1, 2022Not Determined
35270242Create StudySelecting External Controls for Internal Cases Using Stratification Score Matching Methods.International journal of environmental research and public healthBusgang, Stefanie A; Waller, Lance A; Colicino, Elena; D'Agostino Jr, Ralph; Hertz-Picciotto, Irva; Gennings, ChrisFebruary 23, 2022Not Determined
35085933Create StudyEnvironmental exposures to pesticides, phthalates, phenols and trace elements are associated with neurodevelopment in the CHARGE study.Environment internationalBennett, Deborah H; Busgang, Stefanie A; Kannan, Kurunthachalam; Parsons, Patrick J; Takazawa, Mari; Palmer, Christopher D; Schmidt, Rebecca J; Doucette, John T; Schweitzer, Julie B; Gennings, Chris; Hertz-Picciotto, IrvaMarch 1, 2022Not Determined
34808292Create StudyNeonatal chemokine markers predict subsequent diagnosis of autism spectrum disorder and delayed development.Brain, behavior, and immunityKim, Danielle Hj; Krakowiak, Paula; Meltzer, Amory; Hertz-Picciotto, Irva; Van de Water, JudyFebruary 1, 2022Not Determined
34561347Create StudyThe Role of Childhood Asthma in Obesity Development: A Nationwide US Multicohort Study.Epidemiology (Cambridge, Mass.)Stratakis, Nikos; Garcia, Erika; Chandran, Aruna; Hsu, Tingju; Alshawabkeh, Akram; Aris, Izzuddin M; Aschner, Judy L; Breton, Carrie; Burbank, Allison; Camargo Jr, Carlos A; Carroll, Kecia N; Chen, Zhanghua; Claud, Erika C; Dabelea, Dana; Dunlop, Anne L; Elliott, Amy J; Ferrara, Assiamira; Ganiban, Jody M; Gern, James E; Gold, Diane R; Gower, William A; Hertz-Picciotto, Irva; Karagas, Margaret R; Karr, Catherine J; Lester, Barry; Leve, Leslie D; Litonjua, Augusto A; Ludena, Yunin; McEvoy, Cindy T; Miller, Rachel L; Mueller, Noel T; O'Connor, Thomas G; Oken, Emily; O'Shea, T Michael; Perera, Frederica; Stanford, Joseph B; Rivera-Spoljaric, Katherine; Rundle, Andrew; Trasande, Leonardo; Wright, Rosalind J; Zhang, Yue; Zhu, Yeyi; Berhane, Kiros; Gilliland, Frank; Chatzi, Lida; program collaborators for Environmental Influences on Child Health OutcomesJanuary 1, 2022Not Determined
34307452Create StudyA Comparison of Serum and Plasma Blood Collection Tubes for the Integration of Epidemiological and Metabolomics Data.Frontiers in molecular biosciencesSotelo-Orozco, Jennie; Chen, Shin-Yu; Hertz-Picciotto, Irva; Slupsky, Carolyn MJanuary 1, 2021Not Determined
34290368Create StudySexually dimorphic neuroanatomical differences relate to ASD-relevant behavioral outcomes in a maternal autoantibody mouse model.Molecular psychiatryBruce, Matthew R; Jones, Karen L; Vernon, Anthony C; Silverman, Jill L; Crawley, Jacqueline N; Ellegood, Jacob; Lerch, Jason P; Van de Water, JudyDecember 1, 2021Not Determined
33750431Create StudyStable DNMT3L overexpression in SH-SY5Y neurons recreates a facet of the genome-wide Down syndrome DNA methylation signature.Epigenetics & chromatinLaufer, Benjamin I; Gomez, J Antonio; Jianu, Julia M; LaSalle, Janine MMarch 9, 2021Not Determined
33483694Create StudyRisk assessment analysis for maternal autoantibody-related autism (MAR-ASD): a subtype of autism.Molecular psychiatryRamirez-Celis, Alexandra; Becker, Martin; Nuño, Miriam; Schauer, Joseph; Aghaeepour, Nima; Van de Water, JudyMay 1, 2021Not Determined
33414730Create StudyAssociation Between Plasma Metabolites and Psychometric Scores Among Children With Developmental Disabilities: Investigating Sex-Differences.Frontiers in psychiatrySotelo-Orozco, Jennie; Abbeduto, Leonard; Hertz-Picciotto, Irva; Slupsky, Carolyn MJanuary 1, 2020Not Determined
33001180Create StudyLow-pass whole genome bisulfite sequencing of neonatal dried blood spots identifies a role for RUNX1 in Down syndrome DNA methylation profiles.Human molecular geneticsLaufer, Benjamin I; Hwang, Hyeyeon; Jianu, Julia M; Mordaunt, Charles E; Korf, Ian F; Hertz-Picciotto, Irva; LaSalle, Janine MJanuary 6, 2021Not Determined
32758449Create StudyEpisignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype.American journal of human geneticsBreen, Michael S; Garg, Paras; Tang, Lara; Mendonca, Danielle; Levy, Tess; Barbosa, Mafalda; Arnett, Anne B; Kurtz-Nelson, Evangeline; Agolini, Emanuele; Battaglia, Agatino; Chiocchetti, Andreas G; Freitag, Christine M; Garcia-Alcon, Alicia; Grammatico, Paola; Hertz-Picciotto, Irva; Ludena-Rodriguez, Yunin; Moreno, Carmen; Novelli, Antonio; Parellada, Mara; Pascolini, Giulia; Tassone, Flora; Grice, Dorothy E; Di Marino, Daniele; Bernier, Raphael A; Kolevzon, Alexander; Sharp, Andrew J; Buxbaum, Joseph D; Siper, Paige M; De Rubeis, SilviaSeptember 3, 2020Not Determined
32636769Create StudyFamily Environment, Neurodevelopmental Risk, and the Environmental Influences on Child Health Outcomes (ECHO) Initiative: Looking Back and Moving Forward.Frontiers in psychiatryBush, Nicole R; Wakschlag, Lauren S; LeWinn, Kaja Z; Hertz-Picciotto, Irva; Nozadi, Sara S; Pieper, Sarah; Lewis, Johnnye; Biezonski, Dominik; Blair, Clancy; Deardorff, Julianna; Neiderhiser, Jenae M; Leve, Leslie D; Elliott, Amy J; Duarte, Cristiane S; Lugo-Candelas, Claudia; O'Shea, T Michael; Avalos, Lyndsay A; Page, Grier P; Posner, JonathanJanuary 1, 2020Not Determined
32361076Create StudyTemporal trends and determinants of serum concentrations of per- and polyfluoroalkyl substances among Northern California mothers with a young child, 2009-2016.Environmental researchKim, Kyunghoon; Bennett, Deborah H; Calafat, Antonia M; Hertz-Picciotto, Irva; Shin, Hyeong-MooJuly 2020Not Determined
32353786Create StudyModeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study.Environmental researchShin, Hyeong-Moo; Bennett, Deborah H; Calafat, Antonia M; Tancredi, Daniel; Hertz-Picciotto, IrvaJuly 2020Not Determined
31812776Create StudyPeptides of neuron specific enolase as potential ASD biomarkers: From discovery to epitope mapping.Brain, behavior, and immunityRamirez-Celis, Alexandra; Edmiston, Elizabeth; Schauer, Joseph; Vu, Tam; Van de Water, JudyFebruary 2020Not Determined
31582732Create StudyMetabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome.Translational psychiatryOrozco, Jennie Sotelo; Hertz-Picciotto, Irva; Abbeduto, Leonard; Slupsky, Carolyn MOctober 2019Not Determined
31248991Create StudyThe CHARGE study: an assessment of parental occupational exposures and autism spectrum disorder.Occupational and environmental medicineMccanlies EC, Ma CC, Gu JK, Fekedulegn D, Sanderson WT, Ludeña-Rodriguez YJ, Hertz-Picciotto ISeptember 2019Not Determined
31094097Create StudyNeonatal vitamin D status in relation to autism spectrum disorder and developmental delay in the CHARGE case-control study.Autism research : official journal of the International Society for Autism ResearchSchmidt, Rebecca J; Niu, Qiaojuan; Eyles, Darryl W; Hansen, Robin L; Iosif, Ana-MariaJune 2019Not Determined
30534090Create StudyAnti-Candida albicans IgG Antibodies in Children With Autism Spectrum Disorders.Frontiers in psychiatryHughes, Heather K; Ashwood, PaulJanuary 1, 2018Not Determined
30520558Create StudySolving for X: Evidence for sex-specific autism biomarkers across multiple transcriptomic studies.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric GeneticsLee, Samuel C; Quinn, Thomas P; Lai, Jerry; Kong, Sek Won; Hertz-Picciotto, Irva; Glatt, Stephen J; Crowley, Tamsyn M; Venkatesh, Svetha; Nguyen, ThinSeptember 2019Not Determined
30483058Create StudyImmune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders.Frontiers in cellular neuroscienceHughes, Heather K; Mills Ko, Emily; Rose, Destanie; Ashwood, PaulJanuary 2018Not Determined
30251184Create StudyThe Gut Microbiota and Dysbiosis in Autism Spectrum Disorders.Current neurology and neuroscience reportsHughes, Heather K; Rose, Destanie; Ashwood, PaulSeptember 2018Not Determined
30136409Create StudyComparison of maternal beliefs about causes of autism spectrum disorder and association with utilization of services and treatments.Child: care, health and developmentChaidez, Virginia; Fernandez Y Garcia, Erik; Wang, Lulu W; Angkustsiri, Kathleen; Krakowiak, Paula; Hertz-Picciotto, Irva; Hansen, Robin LNovember 2018Not Determined
29955164Create StudyAutism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism.Molecular psychiatryJones, Karen L; Pride, Michael C; Edmiston, Elizabeth; Yang, Mu; Silverman, Jill L; Crawley, Jacqueline N; Van de Water, JudyNovember 2020Not Determined
29934547Create StudyMaternal autoantibody related autism: mechanisms and pathways.Molecular psychiatryJones, Karen L; Van de Water, JudyFebruary 2019Not Determined
29594156Create StudyAffectionate Interactions of Cats with Children Having Autism Spectrum Disorder.Frontiers in veterinary scienceHart, Lynette A; Thigpen, Abigail P; Willits, Neil H; Lyons, Leslie A; Hertz-Picciotto, Irva; Hart, Benjamin LJanuary 2018Not Determined
29573218Create StudyUnderstanding environmental contributions to autism: Causal concepts and the state of science.Autism research : official journal of the International Society for Autism ResearchHertz-Picciotto I, Schmidt RJ, Krakowiak PApril 2018Not Determined
29571898Create StudyDifferential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms.Brain, behavior, and immunityRose, Destanie R; Yang, Houa; Serena, Gloria; Sturgeon, Craig; Ma, Bing; Careaga, Milo; Hughes, Heather K; Angkustsiri, Kathy; Rose, Melissa; Hertz-Picciotto, Irva; Van de Water, Judy; Hansen, Robin L; Ravel, Jacques; Fasano, Alessio; Ashwood, PaulMay 2018Not Determined
29289663Create StudyIdentification of the antigenic epitopes of maternal autoantibodies in autism spectrum disorders.Brain, behavior, and immunityEdmiston, Elizabeth; Jones, Karen L; Vu, Tam; Ashwood, Paul; Van de Water, JudyMarch 2018Not Determined
29276530Create StudyInattention and hyperactivity in association with autism spectrum disorders in the CHARGE study.Research in autism spectrum disordersLyall, Kristen; Schweitzer, Julie B; Schmidt, Rebecca J; Hertz-Picciotto, Irva; Solomon, MarjorieMarch 2017Not Determined
29120534Create StudyJoint effects of prenatal air pollutant exposure and maternal folic acid supplementation on risk of autism spectrum disorder.Autism research : official journal of the International Society for Autism ResearchGoodrich, Amanda J; Volk, Heather E; Tancredi, Daniel J; McConnell, Rob; Lurmann, Fred W; Hansen, Robin L; Schmidt, Rebecca JJanuary 2018Not Determined
28934093Create StudyCombined Prenatal Pesticide Exposure and Folic Acid Intake in Relation to Autism Spectrum Disorder.Environmental health perspectivesSchmidt RJ, Kogan V, Shelton JF, Delwiche L, Hansen RL, Ozonoff S, Ma CC, Mccanlies EC, Bennett DH, Hertz-Picciotto I, Tancredi DJ, Volk HESeptember 2017Not Determined
28921105Create StudyAssociation Between Air Pollution Exposure, Cognitive and Adaptive Function, and ASD Severity Among Children with Autism Spectrum Disorder.Journal of autism and developmental disordersKerin, Tara; Volk, Heather; Li, Weiyan; Lurmann, Fred; Eckel, Sandrah; McConnell, Rob; Hertz-Picciotto, IrvaJanuary 2018Not Determined
28820892Create StudyMaternal autoimmune antibodies alter the dendritic arbor and spine numbers in the infragranular layers of the cortex.PloS oneAriza, Jeanelle; Hurtado, Jesus; Rogers, Haille; Ikeda, Raymond; Dill, Michael; Steward, Craig; Creary, Donnay; Van de Water, Judy; Martínez-Cerdeño, VerónicaJanuary 1, 2017Not Determined
28448694Create StudyThe joint effect of air pollution exposure and copy number variation on risk for autism.Autism research : official journal of the International Society for Autism ResearchKim, Dokyoon; Volk, Heather; Girirajan, Santhosh; Pendergrass, Sarah; Hall, Molly A; Verma, Shefali S; Schmidt, Rebecca J; Hansen, Robin L; Ghosh, Debashis; Ludena-Rodriguez, Yunin; Kim, Kyoungmi; Ritchie, Marylyn D; Hertz-Picciotto, Irva; Selleck, Scott BSeptember 2017Not Determined
28340985Create StudyAutoimmunity, Autoantibodies, and Autism Spectrum Disorder.Biological psychiatryEdmiston, Elizabeth; Ashwood, Paul; Van de Water, JudyMarch 2017Not Relevant
27862943Create StudyBlood transcriptomic comparison of individuals with and without autism spectrum disorder: A combined-samples mega-analysis.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric GeneticsTylee, Daniel S; Hess, Jonathan L; Quinn, Thomas P; Barve, Rahul; Huang, Hailiang; Zhang-James, Yanli; Chang, Jeffrey; Stamova, Boryana S; Sharp, Frank R; Hertz-Picciotto, Irva; Faraone, Stephen V; Kong, Sek Won; Glatt, Stephen JApril 2017Not Relevant
27846226Create StudyPleiotropic Mechanisms Indicated for Sex Differences in Autism.PLoS geneticsMitra, Ileena; Tsang, Kathryn; Ladd-Acosta, Christine; Croen, Lisa A; Aldinger, Kimberly A; Hendren, Robert L; Traglia, Michela; Lavillaureix, Alinoë; Zaitlen, Noah; Oldham, Michael C; Levitt, Pat; Nelson, Stanley; Amaral, David G; Hertz-Picciotto, Irva; Fallin, M Daniele; Weiss, Lauren ANovember 1, 2016Not Determined
27639855Create StudySociodemographic Disparities in Intervention Service Utilization in Families of Children with Autism Spectrum Disorder.Journal of autism and developmental disordersNguyen, Cathina T; Krakowiak, Paula; Hansen, Robin; Hertz-Picciotto, Irva; Angkustsiri, KathleenDecember 2016Not Determined
27534269Create StudyThe Role of the Immune System in Autism Spectrum Disorder.Neuropsychopharmacology : official publication of the American College of NeuropsychopharmacologyMeltzer, Amory; Van de Water, JudyJanuary 2017Not Relevant
27312731Create StudyAutism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions.Autism research : official journal of the International Society for Autism ResearchKrakowiak P, Walker CK, Tancredi D, Hertz-Picciotto I, Van De Water JJune 17, 2016Not Determined
27071785Create StudyAutism, Mitochondria and Polybrominated Diphenyl Ether Exposure.CNS & neurological disorders drug targetsWong, Sarah; Giulivi, CeciliaJanuary 2016Not Relevant
27033107Create StudyRole of p53, Mitochondrial DNA Deletions, and Paternal Age in Autism: A Case-Control Study.PediatricsWong, Sarah; Napoli, Eleonora; Krakowiak, Paula; Tassone, Flora; Hertz-Picciotto, Irva; Giulivi, CeciliaApril 2016Not Determined
27015098Create StudySpending by California''s Department of Developmental Services for Persons with Autism across Demographic and Expenditure Categories.PloS oneLeigh, J Paul; Grosse, Scott D; Cassady, Diana; Melnikow, Joy; Hertz-Picciotto, IrvaJanuary 2016Not Relevant
26725748Create StudyRisk factors in autism: Thinking outside the brain.Journal of autoimmunityMatelski L, Van De Water JFebruary 2016Not Relevant
26392128Create StudyNeonatal Cytokine Profiles Associated With Autism Spectrum Disorder.Biological psychiatryKrakowiak, Paula; Goines, Paula E; Tancredi, Daniel J; Ashwood, Paul; Hansen, Robin L; Hertz-Picciotto, Irva; Van de Water, JudyMarch 1, 2017Not Determined
26298322Create StudyIncreased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.Journal of neuroimmunologyAkintunde, Marjannie Eloi; Rose, Melissa; Krakowiak, Paula; Heuer, Luke; Ashwood, Paul; Hansen, Robin; Hertz-Picciotto, Irva; Van de Water, JudySeptember 15, 2015Not Determined
26198445Create StudyPrenatal mercury exposure, autism, and developmental delay, using pharmacokinetic combination of newborn blood concentrations and questionnaire data: a case control study.Environmental health : a global access science sourceMcKean SJ, Bartell SM, Hansen RL, Barfod GH, Green PG, Hertz-Picciotto I2015Not Determined
26108271Create StudyPhthalate concentrations in house dust in relation to autism spectrum disorder and developmental delay in the CHildhood Autism Risks from Genetics and the Environment (CHARGE) study.Environmental health : a global access science sourcePhilippat C, Bennett DH, Krakowiak P, Rose M, Hwang HM, Hertz-Picciotto I2015Not Determined
26073892Create StudySelected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE Study.Early human developmentSchmidt, Rebecca J; Hansen, Robin L; Hartiala, Jaana; Allayee, Hooman; Sconberg, Jaime L; Schmidt, Linda C; Volk, Heather E; Tassone, FloraAugust 2015Not Determined
26030513Create StudyPreeclampsia, placental insufficiency, autism, and antiphospholipid antibodies-reply.JAMA pediatricsWalker CK, Ashwood P, Hertz-Picciotto IJune 2015Not Relevant
25929801Create StudyExposure to select phthalates and phenols through use of personal care products among Californian adults and their children.Environmental researchPhilippat, Claire; Bennett, Deborah; Calafat, Antonia M; Picciotto, Irva HertzJuly 1, 2015Not Determined
25722050Create StudyAsthma and Allergies in Children With Autism Spectrum Disorders: Results From the CHARGE Study.Autism research : official journal of the International Society for Autism ResearchLyall, Kristen; Van de Water, Judy; Ashwood, Paul; Hertz-Picciotto, IrvaOctober 2015Not Determined
25656730Create StudyMaternal Recall Versus Medical Records of Metabolic Conditions from the Prenatal Period: A Validation Study.Maternal and child health journalKrakowiak P, Walker CK, Tancredi DJ, Hertz-Picciotto ISeptember 2015Not Determined
25485869Create StudyPreeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay.JAMA pediatricsWalker CK, Krakowiak P, Baker A, Hansen RL, Ozonoff S, Hertz-Picciotto IFebruary 2015Not Determined
25249546Create StudyMaternal intake of supplemental iron and risk of autism spectrum disorder.American journal of epidemiologySchmidt, Rebecca J; Tancredi, Daniel J; Krakowiak, Paula; Hansen, Robin L; Ozonoff, SallyNovember 1, 2014Not Determined
25072037Create StudyPotential therapeutic use of the ketogenic diet in autism spectrum disorders.Frontiers in pediatricsNapoli, Eleonora; Dueñas, Nadia; Giulivi, CeciliaJanuary 1, 2014Not Determined
24954055Create StudyNeurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study.Environmental health perspectivesShelton JF, Geraghty EM, Tancredi DJ, Delwiche LD, Schmidt RJ, Ritz B, Hansen RL, Hertz-Picciotto IOctober 2014Not Determined
24809045Create StudyGrand challenges in cellular biochemistry: the "next-gen" biochemistry.Frontiers in chemistryGiulivi, CeciliaJanuary 1, 2014Not Determined
24753527Create StudyDeficits in bioenergetics and impaired immune response in granulocytes from children with autism.PediatricsNapoli E, Wong S, Hertz-Picciotto I, Giulivi CMay 2014Not Determined
24733881Create StudyPrenatal SSRI use and offspring with autism spectrum disorder or developmental delay.PediatricsHarrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto IMay 2014Not Determined
24613242Create StudyEmbryonic intraventricular exposure to autism-specific maternal autoantibodies produces alterations in autistic-like stereotypical behaviors in offspring mice.Behavioural brain researchCamacho, Jasmin; Jones, Karen; Miller, Elaine; Ariza, Jeanelle; Noctor, Stephen; de Water, Judy Van; Martínez-Cerdeño, VerónicaJune 1, 2014Not Determined
24518932Create StudyMaternal lifestyle and environmental risk factors for autism spectrum disorders.International journal of epidemiologyLyall, Kristen; Schmidt, Rebecca J; Hertz-Picciotto, IrvaApril 2014Not Determined
24456651Create StudyAutism spectrum disorder, flea and tick medication, and adjustments for exposure misclassification: the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study.Environmental health : a global access science sourceKeil AP, Daniels JL, Hertz-Picciotto I2014Not Determined
24399100Create StudyUtilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study.Journal of developmental and behavioral pediatrics : JDBPAkins RS, Krakowiak P, Angkustsiri K, Hertz-Picciotto I, Hansen RLJanuary 2014Not Determined
24389156Create StudyAnti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.Brain, behavior, and immunityPiras IS, Haapanen L, Napolioni V, Sacco R, Van de Water J, Persico AMMay 2014Not Determined
24337796Create StudyMaternal immune-mediated conditions, autism spectrum disorders, and developmental delay.Journal of autism and developmental disordersLyall, Kristen; Ashwood, Paul; Van de Water, Judy; Hertz-Picciotto, IrvaJuly 2014Not Determined
24332449Create StudyReduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.Neurobiology of agingPretto DI, Kumar M, Cao Z, Cunningham CL, Durbin-Johnson B, Qi L, Berman R, Noctor SC, Hagerman RJ, Pessah IN, Tassone FMay 2014Not Determined
24240654Create StudyAutism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene.Epidemiology (Cambridge, Mass.)Volk, Heather E; Kerin, Tara; Lurmann, Fred; Hertz-Picciotto, Irva; McConnell, Rob; Campbell, Daniel BJanuary 2014Not Determined
24193577Create StudyGastrointestinal problems in children with autism, developmental delays or typical development.Journal of autism and developmental disordersChaidez, Virginia; Hansen, Robin L; Hertz-Picciotto, IrvaMay 2014Not Determined
24174712Create StudyIncreased anti-phospholipid antibodies in autism spectrum disorders.Mediators of inflammationCareaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P2013Not Determined
24174710Create StudyGestational exposure to a viral mimetic poly(i:C) results in long-lasting changes in mitochondrial function by leucocytes in the adult offspring.Mediators of inflammationGiulivi, Cecilia; Napoli, Eleonora; Schwartzer, Jared; Careaga, Milo; Ashwood, Paul2013Not Determined
23965925Create StudyInfertility and its treatments in association with autism spectrum disorders: a review and results from the CHARGE study.International journal of environmental research and public healthLyall K, Baker A, Hertz-Picciotto I, Walker CKAugust 2013Not Determined
23838888Create StudyAutism-specific maternal autoantibodies recognize critical proteins in developing brain.Translational psychiatryBraunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen RL, Ashwood P, Hertz-Picciotto I, Pessah IN, Van de Water J2013Not Determined
23623455Create StudyTrophoblast inclusions are significantly increased in the placentas of children in families at risk for autism.Biological psychiatryWalker, Cheryl K; Anderson, Kaitlin W; Milano, Kristin M; Ye, Saier; Tancredi, Daniel J; Pessah, Isaac N; Hertz-Picciotto, Irva; Kliman, Harvey JAugust 1, 2013Not Determined
23535821Create StudyGlobal increases in both common and rare copy number load associated with autism.Human molecular geneticsGirirajan S, Johnson RL, Tassone F, Balciuniene J, Katiyar N, Fox K, Baker C, Srikanth A, Yeoh KH, Khoo SJ, Nauth TB, Hansen R, Ritchie M, Hertz-Picciotto I, Eichler EE, Pessah IN, Selleck SBJuly 15, 2013Not Determined
23404082Create StudyTraffic-related air pollution, particulate matter, and autism.JAMA psychiatryVolk, Heather E; Lurmann, Fred; Penfold, Bryan; Hertz-Picciotto, Irva; McConnell, RobJanuary 2013Not Determined
23347615Create StudyEvidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism.Molecular autismNapoli E, Wong S, Giulivi CJanuary 2013Not Determined
23086694Create StudyToxicokinetic modeling of persistent organic pollutant levels in blood from birth to 45 months of age in longitudinal birth cohort studies.Environmental health perspectivesVerner MA, Sonneborn D, Lancz K, Muckle G, Ayotte P, Dewailly É, Kocan A, Palkovicová L, Trnovec T, Haddad S, Hertz-Picciotto I, Eggesbø MJanuary 2013Not Determined
22854260Create StudyDecreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction.Journal of neuroimmunologyHeuer LS, Rose M, Ashwood P, Van de Water JOctober 15, 2012Not Determined
22833194Create StudyAssociation of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression.Translational psychiatryHeuer L, Braunschweig D, Ashwood P, Van de Water J, Campbell DB2011Not Determined
22767137Create StudyIdentification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study.Journal of autism and developmental disordersTassone F, Choudhary NS, Tassone F, Durbin-Johnson B, Hansen R, Hertz-Picciotto I, Pessah IMarch 2013Not Determined
22689191Create StudyMaternal autoantibodies in autism.Archives of neurologyBraunschweig D, Van de Water JJune 2012Not Determined
22648721Create StudyMaternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study.The American journal of clinical nutritionSchmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tassone F, Hertz-Picciotto IJuly 2012Not Determined
22562209Create StudyIs maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study.Journal of autism and developmental disordersZerbo O, Iosif AM, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto IJanuary 2013Not Determined
22534084Create StudyTipping the balance of autism risk: potential mechanisms linking pesticides and autism.Environmental health perspectivesShelton JF, Hertz-Picciotto I, Pessah INJuly 2012Not Determined
22492772Create StudyMaternal metabolic conditions and risk for autism and other neurodevelopmental disorders.PediatricsKrakowiak, Paula; Walker, Cheryl K; Bremer, Andrew A; Baker, Alice S; Ozonoff, Sally; Hansen, Robin L; Hertz-Picciotto, IrvaMay 2012Not Determined
22399446Create StudyAutism spectrum disorders in Hispanics and non-Hispanics.Autism : the international journal of research and practiceChaidez V, Hansen RL, Hertz-Picciotto IJuly 2012Not Determined
22399411Create StudyParental occupational exposures and autism spectrum disorder.Journal of autism and developmental disordersMcCanlies EC, Fekedulegn D, Mnatsakanova A, Burchfiel CM, Sanderson WT, Charles LE, Hertz-Picciotto INovember 2012Not Determined
22275729Create StudyPre- and postnatal polychlorinated biphenyl concentrations and longitudinal measures of thymus volume in infants.Environmental health perspectivesJusko TA, Sonneborn D, Palkovicova L, Kocan A, Drobna B, Trnovec T, Hertz-Picciotto IApril 2012Not Determined
21610500Create StudyPrenatal vitamins, one-carbon metabolism gene variants, and risk for autism.Epidemiology (Cambridge, Mass.)Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tancredi DJ, Tassone F, Hertz-Picciotto IJuly 2011Not Determined
21610186Create StudyMinor physical anomalies in children with autism spectrum disorders.Autism : the international journal of research and practiceAngkustsiri K, Krakowiak P, Moghaddam B, Wardinsky T, Gardner J, Kalamkarian N, Hertz-Picciotto I, Hansen RLNovember 2011Not Determined
21543984Create StudyMonth of conception and risk of autism.Epidemiology (Cambridge, Mass.)Zerbo O, Iosif AM, Delwiche L, Walker C, Hertz-Picciotto IJuly 2011Not Determined
21538940Create StudyMAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.Autism research : official journal of the International Society for Autism ResearchTassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto IAugust 2011Not Determined
21205326Create StudyPolybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study.Environmental health : a global access science sourceHertz-Picciotto I, Bergman A, Fängström B, Rose M, Krakowiak P, Pessah I, Hansen R, Bennett DH2011Not Determined
21156395Create StudyResidential proximity to freeways and autism in the CHARGE study.Environmental health perspectivesVolk, Heather E; Hertz-Picciotto, Irva; Delwiche, Lora; Lurmann, Fred; McConnell, RobJune 2011Not Determined
21134442Create StudyAutoantibodies to cerebellum in children with autism associate with behavior.Brain, behavior, and immunityGoines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L, Hansen R, Hertz-Picciotto I, Ashwood P, Van de Water JMarch 2011Not Determined
21119085Create StudyMitochondrial dysfunction in autism.JAMAGiulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, Pessah INDecember 1, 2010Not Determined
21095018Create StudyAssociations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.Journal of neuroimmunologyAshwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water JMarch 2011Not Determined
20833247Create StudyAltered T cell responses in children with autism.Brain, behavior, and immunityAshwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water JJuly 2011Not Determined
20806403Create StudyA comparison of multiple imputation and fully augmented weighted estimators for Cox regression with missing covariates.Statistics in medicineQi L, Wang YF, He YNovember 10, 2010Not Determined
20731829Create StudyNeurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity: a birth cohort study.Environmental health : a global access science sourcePark HY, Hertz-Picciotto I, Sovcikova E, Kocan A, Drobna B, Trnovec T2010Not Determined
20705131Create StudyElevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.Brain, behavior, and immunityAshwood, Paul; Krakowiak, Paula; Hertz-Picciotto, Irva; Hansen, Robin; Pessah, Isaac; Van de Water, JudyJanuary 2011Not Determined
20466021Create StudyEarly onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins.NeurotoxicologyPaul R, Pessah IN, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman RAugust 2010Not Determined
20196589Create StudyPBDEs in 2-5 year-old children from California and associations with diet and indoor environment.Environmental science & technologyRose M, Bennett DH, Bergman A, Fängström B, Pessah IN, Hertz-Picciotto IApril 1, 2010Not Determined
20160651Create StudyThe immune system's role in the biology of autism.Current opinion in neurologyGoines P, Van de Water JApril 2010Not Determined
20143326Create StudyIndependent and dependent contributions of advanced maternal and paternal ages to autism risk.Autism research : official journal of the International Society for Autism ResearchShelton JF, Tancredi DJ, Hertz-Picciotto IFebruary 2010Not Determined
20056569Create StudyBlood mercury concentrations in CHARGE Study children with and without autism.Environmental health perspectivesHertz-Picciotto, Irva; Green, Peter G; Delwiche, Lora; Hansen, Robin; Walker, Cheryl; Pessah, Isaac NJanuary 2010Not Determined
20049980Create StudyGeographic distribution of autism in California: a retrospective birth cohort analysis.Autism research : official journal of the International Society for Autism ResearchVan Meter KC, Christiansen LE, Delwiche LD, Azari R, Carpenter TE, Hertz-Picciotto IFebruary 2010Not Determined
19937285Create StudyCorrelations between gene expression and mercury levels in blood of boys with and without autism.Neurotoxicity researchStamova, Boryana; Green, Peter G; Tian, Yingfang; Hertz-Picciotto, Irva; Pessah, Isaac N; Hansen, Robin; Yang, Xiaowei; Teng, Jennifer; Gregg, Jeffrey P; Ashwood, Paul; Van de Water, Judy; Sharp, Frank RJanuary 2011Not Determined
19921347Create StudyCorrelations of gene expression with blood lead levels in children with autism compared to typically developing controls.Neurotoxicity researchTian, Yingfang; Green, Peter G; Stamova, Boryana; Hertz-Picciotto, Irva; Pessah, Isaac N; Hansen, Robin; Yang, Xiaowei; Gregg, Jeffrey P; Ashwood, Paul; Jickling, Glen; Van de Water, Judy; Sharp, Frank RJanuary 2011Not Determined
19800697Create StudyDecreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders.Journal of neuroimmunologyOnore, Charity; Enstrom, Amanda; Krakowiak, Paula; Hertz-Picciotto, Irva; Hansen, Robin; Van de Water, Judy; Ashwood, PaulNovember 30, 2009Not Determined
19737792Create StudyCommentary: Diagnostic change and the increased prevalence of autism.International journal of epidemiologyHertz-Picciotto IOctober 2009Not Determined
19666104Create StudyDifferential monocyte responses to TLR ligands in children with autism spectrum disorders.Brain, behavior, and immunityEnstrom AM, Onore CE, Van de Water JA, Ashwood PJanuary 2010Not Determined
19647017Create StudyWITHDRAWN: Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity in a birth cohort.NeurotoxicologyPark HY, Hertz-Picciotto I, Sovcikova E, Kocan A, Trnovec TJuly 30, 2009Not Determined
19360687Create StudyThe onset of autism: patterns of symptom emergence in the first years of life.Autism research : official journal of the International Society for Autism ResearchOzonoff, Sally; Heung, Kelly; Byrd, Robert; Hansen, Robin; Hertz-Picciotto, IrvaDecember 2008Not Determined
19343198Create StudyReduced levels of immunoglobulin in children with autism correlates with behavioral symptoms.Autism research : official journal of the International Society for Autism ResearchHeuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water JOctober 2008Not Determined
19307110Create StudyPlasma fatty acid profiles in autism: a case-control study.Prostaglandins, leukotrienes, and essential fatty acidsWiest MM, German JB, Harvey DJ, Watkins SM, Hertz-Picciotto IApril 2009Not Determined
19234401Create StudyThe rise in autism and the role of age at diagnosis.Epidemiology (Cambridge, Mass.)Hertz-Picciotto I, Delwiche LJanuary 2009Not Determined
19211157Create StudyPreliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.Journal of neuroimmunologyAshwood P, Schauer J, Pessah IN, Van de Water JMarch 31, 2009Not Determined
19136055Create StudyIncreased IgG4 levels in children with autism disorder.Brain, behavior, and immunityEnstrom A, Krakowiak P, Onore C, Pessah IN, Hertz-Picciotto I, Hansen RL, Van de Water JA, Ashwood PMarch 2009Not Determined
19132145Create StudyMECP2 promoter methylation and X chromosome inactivation in autism.Autism research : official journal of the International Society for Autism ResearchNagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, Hansen RL, Van de Water J, Pessah IN, Jiang R, Robinson WP, LaSalle JMJune 2008Not Determined
18762342Create StudyDecreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.Journal of neuroimmunologyAshwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, Van de Water JNovember 15, 2008Not Determined
18762240Create StudyAltered gene expression and function of peripheral blood natural killer cells in children with autism.Brain, behavior, and immunityEnstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Sharp FR, Ashwood PJanuary 2009Not Determined
18627595Create StudyA cohort study of in utero polychlorinated biphenyl (PCB) exposures in relation to secondary sex ratio.Environmental health : a global access science sourceHertz-Picciotto I, Jusko TA, Willman EJ, Baker RJ, Keller JA, Teplin SW, Charles MJ2008Not Determined
18507863Create StudyA procedure to characterize geographic distributions of rare disorders in cohorts.International journal of health geographicsVan Meter KC, Christiansen LE, Hertz-Picciotto I, Azari R, Carpenter TE2008Not Determined
18482108Create StudySleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study.Journal of sleep researchKrakowiak, Paula; Goodlin-Jones, Beth; Hertz-Picciotto, Irva; Croen, Lisa A; Hansen, Robin LJune 2008Not Determined
18426515Create StudyPrenatal polychlorinated biphenyl exposures in eastern Slovakia modify effects of social factors on birthweight.Paediatric and perinatal epidemiologySonneborn D, Park HY, Petrik J, Kocan A, Palkovicova L, Trnovec T, Nguyen D, Hertz-Picciotto IMay 2008Not Determined
18285840Create StudySerum PCB concentrations in relation to locally produced food items in eastern Slovakia.Journal of exposure science & environmental epidemiologySonneborn D, Park HY, Babinska K, Palkovicova L, Trnovec T, Kocan A, Nguyen DV, Hertz-Picciotto INovember 2008Not Determined
18191778Create StudyRegression in autism: prevalence and associated factors in the CHARGE Study.Ambulatory pediatrics : the official journal of the Ambulatory Pediatric AssociationHansen, Robin L; Ozonoff, Sally; Krakowiak, Paula; Angkustsiri, Kathleen; Jones, Carrie; Deprey, Lesley J; Le, Dung-Nghi; Croen, Lisa A; Hertz-Picciotto, IrvaJanuary 2008Not Determined
18078998Create StudyAutism: maternally derived antibodies specific for fetal brain proteins.NeurotoxicologyBraunschweig D, Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water JMarch 2008Not Determined
18006270Create StudyGene expression changes in children with autism.GenomicsGregg JP, Lit L, Baron CA, Hertz-Picciotto I, Walker W, Davis RA, Croen LA, Ozonoff S, Hansen R, Pessah IN, Sharp FRJanuary 2008Not Determined
17347881Create StudyBrief report: plasma leptin levels are elevated in autism: association with early onset phenotype?Journal of autism and developmental disordersAshwood P, Kwong C, Hansen R, Hertz-Picciotto I, Croen L, Krakowiak P, Walker W, Pessah IN, Van de Water JJanuary 2008Not Determined
helpcenter.collection.publications-tab

NDA Help Center

Collection - Publications

The number of Publications is displayed in parentheses next to the tab name. Clicking on any of the Publication Titles will open the Publication in a new internet browsing tab.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may mark a publication as either Relevant or Not Relevant in the Status column.

Frequently Asked Questions

  • How can I determine if a publication is relevant?
    Publications are considered relevant to a collection when the data shared is directly related to the project or collection.
  • Where does the NDA get the publications?
    PubMed, an online library containing journals, articles, and medical research. Sponsored by NiH and National Library of Medicine (NLM).

Glossary

  • Create Study
    A link to the Create an NDA Study page that can be clicked to start creating an NDA Study with information such as the title, journal and authors automatically populated.
  • Not Determined Publication
    Indicates that the publication has not yet been reviewed and/or marked as Relevant or Not Relevant so it has not been determined whether an NDA Study is expected.
  • Not Relevant Publication
    A publication that is not based on data related to the aims of the grant/project associated with the Collection or not based on any data such as a review article and, therefore, an NDA Study is not expected to be created.
  • PubMed
    PubMed provides citation information for biomedical and life sciences publications and is managed by the U.S. National Institutes of Health's National Library of Medicine.
  • PubMed ID
    The PUBMed ID is the unique ID number for the publication as recorded in the PubMed database.
  • Relevant Publication
    A publication that is based on data related to the aims of the grant/project associated with the Collection and, therefore, an NDA Study is expected to be created.

Relevant Publications
PubMed IDStudyTitleJournalAuthorsDate
No records found.
Data Expected List: Mandatory Data Structures

These data structures are mandatory for your NDA Collection. Please update the Targeted Enrollment number to accurately represent the number of subjects you expect to submit for the entire study.

Data ExpectedTargeted EnrollmentInitial SubmissionSubjects SharedStatus
Research Subject and Pedigree info icon
1105/13/2015
551
Approved

You can use "Add New Data Expected" to add exsiting structures and create your project's list. However, this is also the method you can use to request new structures be created for your project. When adding the Data Expected item, if the structure already exists you can locate it and specify your dates and enrollment. To add a new structure and request it be defined in the Data Dictionary, select Upload Definition and attach the definition or material needed to create it, including manual, codebooks, forms, etc. If you have multiple files, please upload a zipped archive containing them all.

Expected dates should be selected based on the standard Data Sharing Regimen and are restricted to within date ranges based on the project start and end dates.

Data Expected List: Data Structures per Research Aims

These data structures are specific to your research aims and should list all data structures in which data will be collected and submitted for this NDA Collection. Please update the Targeted Enrollment number to accurately represent the number of subjects you expect to submit for the entire study.

Data ExpectedTargeted EnrollmentInitial SubmissionSubjects SharedStatus
Mullen Scales of Early Learning info icon
1105/13/2015
551
Approved
Genomics/omics info icon
9901/15/2015
0
Approved
ABC Community info icon
9901/15/2015
545
Approved
ADOS info icon
9901/15/2015
343
Approved
ADI-R info icon
33607/15/2014
378
Approved
Early Development Questionnaire info icon
38201/15/2015
498
Approved
Medical History info icon
70007/15/2014
549
Approved
Genetic Test info icon
9901/15/2015
0
Approved
Social Communication Questionnaire (SCQ) info icon
9901/15/2015
227
Approved
Demographics info icon
70001/15/2016
552
Approved
Enviromental Evaluation info icon
9901/15/2015
538
Approved
Sleep History info icon
9907/15/2015
549
Approved
Physical Exam info icon
9901/15/2015
366
Approved
Vineland (Parent and Caregiver) info icon
70007/15/2014
595
Approved
Product Questionnaire info icon
9901/15/2015
0
Approved
Structure not yet defined
No Status history for this Data Expected has been recorded yet
helpcenter.collection.data-expected-tab

NDA Help Center

Collection - Data Expected

The Data Expected tab displays the list of all data that NDA expects to receive in association with the Collection as defined by the contributing researcher, as well as the dates for the expected initial upload of the data, and when it is first expected to be shared, or with the research community. Above the primary table of Data Expected, any publications determined to be relevant to the data within the Collection are also displayed - members of the contributing research group can use these to define NDA Studies, connecting those papers to underlying data in NDA.

The tab is used both as a reference for those accessing shared data, providing information on what is expected and when it will be shared, and as the primary tracking mechanism for contributing projects. It is used by both contributing primary researchers, secondary researchers, and NIH Program and Grants Management staff.

Contributing researchers just getting started on their project will need to define this list by adding all of the items they are collecting under their grant and setting their schedule according to the NDA Data Sharing Regimen. If you fall into this category, you can begin by clicking "Add New Data Expected" and selecting which data structures you will be using, saving the page after each change, or requesting new structures by adding and naming a new item, providing any materials NDA Data Dictionary Curators can use to help define your structure. For more information see the tutorial on creating Data Expected.

If you are a contributing researcher creating this list for the first time, or making changes to the list as your project progress, please note the following:

  • Although items you add to the list and changes you make are displayed, they are not committed to the system until you Save the entire page using the "Save"" button at the bottom of your screen. Please Save after every change to ensure none of your work is lost.
  • If you attempt to add a new structure, the title you provide must be unique - if another structure exists with the same name your change will fail.
  • Adding a new structure to this list is the only way to request the creation of a new Data Dictionary definition.

Frequently Asked Questions

  • What is an NDA Data Structure?
    An NDA Data Structure is comprised of multiple Data Elements to make up an electronic definition of an assessment, measure, questionnaire, etc will have a corresponding Data Structure.
  • What is the NDA Data Dictionary?
    The NDA Data Dictionary is comprised of electronic definitions known as Data Structures.

Glossary

  • Analyzed Data
    Data specific to the primary aims of the research being conducted (e.g. outcome measures, other dependent variables, observations, laboratory results, analyzed images, volumetric data, etc.) including processed images.
  • Data Item
    Items listed on the Data Expected list in the Collection which may be an individual and discrete Data Structure, Data Structure Category, or Data Structure Group.
  • Data Structure
    A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure
  • Data Structure Category
    An NDA term describing the affiliation of a Data Structure to a Category, which may be disease/disorder or diagnosis related (Depression, ADHD, Psychosis), specific to data type (MRI, eye tracking, omics), or type of data (physical exam, IQ).
  • Data Structure Group
    A Data Item listed on the Data Expected tab of a Collection that indicates a group of Data Structures (e.g., ADOS or SCID) for which data may be submitted instead of a specific Data Structure identified by version, module, edition, etc. For example, the ADOS Data Structure Category includes every ADOS Data Structure such as ADOS Module 1, ADOS Module 2, ADOS Module 1 - 2nd Edition, etc. The SCID Data Structure Group includes every SCID Data Structure such as SCID Mania, SCID V Mania, SCID PTSD, SCID-V Diagnosis, and more.
  • Evaluated Data
    A new Data Structure category, Evaluated Data is analyzed data resulting from the use of computational pipelines in the Cloud and can be uploaded directly back to a miNDAR database. Evaluated Data is expected to be listed as a Data Item in the Collection's Data Expected Tab.
  • Imaging Data
    Imaging+ is an NDA term which encompasses all imaging related data including, but not limited to, images (DTI, MRI, PET, Structural, Spectroscopy, etc.) as well as neurosignal data (EEG, fMRI, MEG, EGG, eye tracking, etc.) and Evaluated Data.
  • Initial Share Date
    Initial Submission and Initial Share dates should be populated according to the NDA Data Sharing Terms and Conditions. Any modifications to these will go through the approval processes outlined above. Data will be shared with authorized users upon publication (via an NDA Study) or 1-2 years after the grant end date specified on the first Notice of Award, as defined in the applicable Data Sharing Terms and Conditions.
  • Initial Submission Date
    Initial Submission and Initial Share dates should be populated according to these NDA Data Sharing Terms and Conditions. Any modifications to these will go through the approval processes outlined above. Data for all subjects is not expected on the Initial Submission Date and modifications may be made as necessary based on the project's conduct.
  • Research Subject and Pedigree
    An NDA created Data Structure used to convey basic information about the subject such as demographics, pedigree (links family GUIDs), diagnosis/phenotype, and sample location that are critical to allow for easier querying of shared data.
  • Submission Cycle
    The NDA has two Submission Cycles per year - January 15 and July 15.
  • Submission Exemption
    An interface to notify NDA that data may not be submitted during the upcoming/current submission cycle.

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Associated Studies

Studies that have been defined using data from a Collection are important criteria to determine the value of data shared. The number of subjects column displays the counts from this Collection that are included in a Study, out of the total number of subjects in that study. The Data Use column represents whether or not the study is a primary analysis of the data or a secondary analysis. State indicates whether the study is private or shared with the research community.

Study NameAbstractCollection/Study SubjectsData UsageState
Examining the validity of the use of ratio IQs in psychological assessments IQ tests are amongst the most used psychological assessments, both in research and clinical settings. For participants who cannot complete IQ tests normed for their age, ratio IQ scores (RIQ) are routinely computed and used as a proxy of IQ, especially in large research databases to avoid missing data points. However, because it has never been scientifically validated, this practice is questionable. In the era of big data, it is important to examine the validity of this widely used practice. In this paper, we use the case of autism to examine the differences between standard full-scale IQ (FSIQ) and RIQ. Data was extracted from four databases in which ages, FSIQ scores and subtests raw scores were available for autistic participants between 2 and 17 years old. The IQ tests included were the MSEL (N=12033), DAS-II early years (N=1270), DAS-II school age (N=2848), WISC-IV (N=471) and WISC-V (N=129). RIQs were computed for each participant as well as the discrepancy (DSC) between RIQ and FSIQ. We performed two linear regressions to respectively assess the effect of FSIQ and of age on the DSC for each IQ test, followed by additional analyses comparing age subgroups as well as FSIQ subgroups on DSC. Participants at the extremes of the FSIQ distribution tended to have a greater DSC than participants with average FSIQ. Furthermore, age significantly predicted the DSC, with RIQ superior to FSIQ for younger participants while the opposite was found for older participants. These results question the validity of this widely used alternative scoring method, especially for individuals at the extremes of the normal distribution, with whom RIQs are most often employed.476/17423Secondary AnalysisShared
Controls for SCCRIPTo establish a well characterized cohort for pediatric patients living with sickle cell disease375/11185Secondary AnalysisPrivate
Characterizing Auditory Hyperreactivity in AutismObjective: To answer the following research questions: 1) What is the prevalence of auditory hyper-reactivity in ASD? 2) Does auditory hyper-reactivity severity change with age? and 3) What are the most common auditory stimuli reported to be bothersome? Research Design: Primarily descriptive secondary data analysis. Methods: Type of data: Questionnaire items regarding auditory hyper-reactivity will be filtered from: Autism Diagnostic Interview-Revised, Sensory Profile (all forms), Sensory Over-Responsivity Scale, and Sensory Experiences Questionnaire in addition to demographics (i.e., age, race, ethnicity, diagnoses). Analysis Plan: Descriptive statistics, tables and figures will be used to summarize the prevalence and severity of auditory hyper-reactivity by age. Linear regression modeling will be used to evaluate changes in auditory hyper-reactivity by age. If data is available for control subjects, statistical analyses will be conducted for means comparison (ASD vs. non-ASD). 304/7001Secondary AnalysisPrivate
Investigating autism etiology and heterogeneity by decision tree algorithmAutism spectrum disorder (ASD) is a neurodevelopmental disorder that causes deficits in cognition, communication and social skills. ASD, however, is a highly heterogeneous disorder. This heterogeneity has made identifying the etiology of ASD a particularly difficult challenge, as patients exhibit a wide spectrum of symptoms without any unifying genetic or environmental factors to account for the disorder. For better understanding of ASD, it is paramount to identify potential genetic and environmental risk factors that are comorbid with it. Identifying such factors is of great importance to determine potential causes for the disorder, and understand its heterogeneity. Existing large-scale datasets offer an opportunity for computer scientists to undertake this task by utilizing machine learning to reliably and efficiently obtain insight about potential ASD risk factors, which would in turn assist in guiding research in the field. In this study, decision tree algorithms were utilized to analyze related factors in datasets obtained from the National Database for Autism Research (NDAR) consisting of nearly 3000 individuals. We were able to identify 15 medical conditions that were highly associated with ASD diagnoses in patients; furthermore, we extended our analysis to the family medical history of patients and we report six potentially hereditary medical conditions associated with ASD. Associations reported had a 90% accuracy. Meanwhile, gender comparisons highlighted conditions that were unique to each gender and others that overlapped. Those findings were validated by the academic literature, thus opening the way for new directions for the use of decision tree algorithms to further understand the etiology of autism. 96/3382Secondary AnalysisShared
Autism Sensory Research Consortium Cross-lab Integrative Data Analysis Since 2013, when sensory features were officially added to the diagnostic criteria for autism, research into the sensory manifestations of the condition has increased dramatically. However, the majority of this research has primarily been conducted using small laboratory-based samples of children on the autism spectrum, substantially limiting the hypotheses that can be tested in any one dataset and the generalizability of results to the wider autistic population. The Autism Sensory Research Consortium (ASRC), funded by the Nancy Lurie Marks Family Foundation, represents the first major international collaboration of over a dozen research groups that study sensory functioning in autism. As a major thrust of this collaboration, the ASRC has begun a data sharing initiative, in which all participating labs can contribute existing data from their past and present research studies to a centralized database. These “Big Data” can then be systematically examined using powerful large-sample statistical techniques such as structural equation modeling and item response theory, which will allow researchers to test more complex hypotheses regarding the nature of sensory differences in autism and their relationships with sociodemographic and non-sensory clinical features. Once data from all sites has been pooled, it will be analyzed using a method called integrative data analysis, which is specially designed to derive insights from large and heterogeneous samples. One major advantage of this methodology is the ability to construct and test measurement models of sensory symptoms, determining the most appropriate set of questions for assessing each construct and making sure that the scales do not produce biased comparisons when they are examined across diagnostic groups or subsets of the autistic population. Furthermore, measurement models can be constructed to bridge multiple questionnaires, allowing for the calculation of robust composite scores that can be compared between studies that only administered items from one of the contributing questionnaires. These models can further facilitate pooling of data across studies, allowing us to amass even larger datasets to answer questions about sensory function in the autistic population. Furthermore, moving forward, the composite sensory measures from the integrative data analysis can be employed in other studies, providing investigators in sensory autism research with a suite of reliable and valid behavioral measures that can be used as outcomes in trials of interventions targeting these symptoms. In the long term, this project has the potential to help us better understand the nature of sensory function in persons on the spectrum, as well as how sensory alterations relate to broader features of the condition—specifically, for whom and/or at what point in development sensory features are most predictive of core autism behaviors or other meaningful clinical outcomes such as language acquisition and adaptive behavior. Incorporation of neuroscientific data collected within the ASRC can also possibly shed some light on the neural basis of sensory disruptions in the autistic population. All of this will help to lay a foundation for future work testing the efficacy of candidate interventions aimed at improving sensory function and more distal skills in autistic individuals.14/2110Secondary AnalysisPrivate
Imbalanced social-communicative and restricted repetitive behavior subtypes in autism spectrum disorder exhibit different neural circuitrySocial-communication (SC) and restricted repetitive behaviors (RRB) are autism diagnostic symptom domains. SC and RRB severity can markedly differ within and between individuals and may be underpinned by different neural circuitry and genetic mechanisms. Modeling SC-RRB balance could help identify how neural circuitry and genetic mechanisms map onto such phenotypic heterogeneity. Here, we developed a phenotypic stratification model that makes highly accurate (97–99%) out-of-sample SC = RRB, SC > RRB, and RRB > SC subtype predictions. Applying this model to resting state fMRI data from the EU-AIMS LEAP dataset (n = 509), we find that while the phenotypic subtypes share many commonalities in terms of intrinsic functional connectivity, they also show replicable differences within some networks compared to a typically-developing group (TD). Specifically, the somatomotor network is hypoconnected with perisylvian circuitry in SC > RRB and visual association circuitry in SC = RRB. The SC = RRB subtype show hyperconnectivity between medial motor and anterior salience circuitry. Genes that are highly expressed within these networks show a differential enrichment pattern with known autism-associated genes, indicating that such circuits are affected by differing autism-associated genomic mechanisms. These results suggest that SC-RRB imbalance subtypes share many commonalities, but also express subtle differences in functional neural circuitry and the genomic underpinnings behind such circuitry.120/1708Secondary AnalysisShared
Gender differences in restricted and repetitive behaviors and interests in autismBackground: The female autism phenotype has been defined by differences in core autism spectrum disorder (ASD) symptomology related to reciprocal social communication and restricted and repetitive behaviors and interests (RRBI). Previous research on RRBI in ASD has found that affected boys have increased stereotyped and restricted behaviors compared to girls with ASD (Hiller, Young, & Weber, 2014; Mandy et al., 2012). Other domains of RRBI (i.e., self-injurious, compulsive, and insistence on sameness behaviors), which contribute to DSM-5 diagnosis, are less studied and have not been examined across gender. To date, no studies have examined gender differences using a comprehensive RRBI measure, which spans stereotyped, self-injurious, compulsive, insistence on sameness, and restricted behavior domains. Objectives: To investigate whether symptoms of RRBI (i.e., stereotyped, self-injurious, ritualistic, compulsive, insistence on sameness, and restricted behavior), as measured by item-level data on the Repetitive Behavior Scale-Revised (RBS-R), can classify males versus females with ASD. Methods: Participants included 615 youth with ASD (507 males; 82.4%), between 3 and 18 years of age (M=10.26, SD=4.20), who agreed to share data with the National Database for Autism Research (NDAR). A stepwise discriminant function analysis (DFA) was used to predict the degree RBS-R data could correctly classify gender in a large sample of individuals with ASD. Standardized canonical function coefficients (SCFC) from the DFA represent the contribution of each variable to the discrimination between groups, with greater SCFC indicating greater discrimination. Results: DFA results suggest that RBS-R items significantly differentiate girls versus boys with ASD, Wilks’ λ=0.89, χ2=70.79, p<0.001. Of note, gender was classified based on a set of 8 items (see table 1). Interestingly, the items that differentiated boys from girls did not solely consist of higher stereotyped and restricted behavior in boys (as indicated by negative SCFC scores). Half of the items that differentiated gender were higher in females with ASD (as indicated by positive SCFC scores) and from the self-injurious, compulsive, and insistence on sameness domains. This set of RBS-R items had greater success in correctly classifying boys with ASD (67.90%) than in correctly classifying affected girls (61.00%). Conclusions: This study extends findings of gender differences in RRBI for ASD, demonstrating that girls with ASD may demonstrate higher self-injurious, compulsive, and insistence on sameness behavior than affected boys. It is important for future research to disentangle whether these elevated rates of RRBI in girls with ASD are central to the female autism phenotype or an epiphenomenon of the high rates of co-occurring disorders (e.g., anxiety) noted in affected girls. 1/612Secondary AnalysisPrivate
Critical test items to differentiate individuals with SPCD from those with ASD and typical controlsSocial (pragmatic) communication disorder (SPCD) is a new category in the DSM-5. This study used IRT modelling to analyze archive data of item responses to the Social Communication Question-Lifetime (SCQ) from the National Database of Autism Research (NDAR), to select critical test items that could efficiently differentiate SPCD from ASD and TD. Methods: The SCQ records were downloaded from the NDAR. The item difficulty values and participants ability in the social communication and repetitive behavior and restricted interests were estimated through Winsteps. The items with difficulty values mostly matching the participants ability at the cut-off zones among three groups were selected. Result: The eight test items were identified for screening SPCD with 75% sensitivity. The specificity for differentiating SPCD from TD and ASD is 86.27% and 68.9% respectively. Conclusion: This study provides a short list of critical items that could be used to screen SPCD from TD and ASD. 2/151Secondary AnalysisPrivate
* Data not on individual level
helpcenter.collection.associated-studies-tab

NDA Help Center

Collection - Associated Studies

Clicking on the Study Title will open the study details in a new internet browser tab. The Abstract is available for viewing, providing the background explanation of the study, as provided by the Collection Owner.

Primary v. Secondary Analysis: The Data Usage column will have one of these two choices. An associated study that is listed as being used for Primary Analysis indicates at least some and potentially all of the data used was originally collected by the creator of the NDA Study. Secondary Analysis indicates the Study owner was not involved in the collection of data, and may be used as supporting data.

Private v. Shared State: Studies that remain private indicate the associated study is only available to users who are able to access the collection. A shared study is accessible to the general public.

Frequently Asked Questions

  • How do I associate a study to my collection?
    Studies are associated to the Collection automatically when the data is defined in the Study.

Glossary

  • Associated Studies Tab
    A tab in a Collection that lists the NDA Studies that have been created using data from that Collection including both Primary and Secondary Analysis NDA Studies.
Edit